Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?</title>
<author><name sortKey="Krammer, Florian" sort="Krammer, Florian" uniqKey="Krammer F" first="Florian" last="Krammer">Florian Krammer</name>
<affiliation><nlm:aff id="aff1"><addr-line>Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff2"><addr-line>Icahn School of Medicine at Mount Sinai, New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Fouchier, Ron A M" sort="Fouchier, Ron A M" uniqKey="Fouchier R" first="Ron A. M." last="Fouchier">Ron A. M. Fouchier</name>
<affiliation><nlm:aff id="aff1"><addr-line>Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff4"><addr-line>Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Eichelberger, Maryna C" sort="Eichelberger, Maryna C" uniqKey="Eichelberger M" first="Maryna C." last="Eichelberger">Maryna C. Eichelberger</name>
<affiliation><nlm:aff id="aff5"><addr-line>Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Webby, Richard J" sort="Webby, Richard J" uniqKey="Webby R" first="Richard J." last="Webby">Richard J. Webby</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff6"><addr-line>St. Jude Center of Excellence for Influenza Research and Surveillance, Memphis, Tennessee, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff7"><addr-line>Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Shaw Saliba, Kathryn" sort="Shaw Saliba, Kathryn" uniqKey="Shaw Saliba K" first="Kathryn" last="Shaw-Saliba">Kathryn Shaw-Saliba</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff8"><addr-line>Johns Hopkins Center of Excellence for Influenza Research and Surveillance, Baltimore, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff9"><addr-line>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff10"><addr-line>W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wan, Hongquan" sort="Wan, Hongquan" uniqKey="Wan H" first="Hongquan" last="Wan">Hongquan Wan</name>
<affiliation><nlm:aff id="aff5"><addr-line>Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wilson, Patrick C" sort="Wilson, Patrick C" uniqKey="Wilson P" first="Patrick C." last="Wilson">Patrick C. Wilson</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff11"><addr-line>New York Influenza Center of Excellence (NYICE), New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff12"><addr-line>Department of Medicine, the Knapp Center for Lupus and Immunology Research, Section of Rheumatology, the University of Chicago, Chicago, Illinois, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Compans, Richard W" sort="Compans, Richard W" uniqKey="Compans R" first="Richard W." last="Compans">Richard W. Compans</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff13"><addr-line>Emory-UGA Center of Excellence for Influenza Research and Surveillance, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff14"><addr-line>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff15"><addr-line>Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Skountzou, Ioanna" sort="Skountzou, Ioanna" uniqKey="Skountzou I" first="Ioanna" last="Skountzou">Ioanna Skountzou</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff13"><addr-line>Emory-UGA Center of Excellence for Influenza Research and Surveillance, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff14"><addr-line>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff15"><addr-line>Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Monto, Arnold S" sort="Monto, Arnold S" uniqKey="Monto A" first="Arnold S." last="Monto">Arnold S. Monto</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff11"><addr-line>New York Influenza Center of Excellence (NYICE), New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff16"><addr-line>Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">29615508</idno>
<idno type="pmc">5885027</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885027</idno>
<idno type="RBID">PMC:5885027</idno>
<idno type="doi">10.1128/mBio.02332-17</idno>
<date when="2018">2018</date>
<idno type="wicri:Area/Pmc/Corpus">000E48</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000E48</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?</title>
<author><name sortKey="Krammer, Florian" sort="Krammer, Florian" uniqKey="Krammer F" first="Florian" last="Krammer">Florian Krammer</name>
<affiliation><nlm:aff id="aff1"><addr-line>Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff2"><addr-line>Icahn School of Medicine at Mount Sinai, New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Fouchier, Ron A M" sort="Fouchier, Ron A M" uniqKey="Fouchier R" first="Ron A. M." last="Fouchier">Ron A. M. Fouchier</name>
<affiliation><nlm:aff id="aff1"><addr-line>Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff4"><addr-line>Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Eichelberger, Maryna C" sort="Eichelberger, Maryna C" uniqKey="Eichelberger M" first="Maryna C." last="Eichelberger">Maryna C. Eichelberger</name>
<affiliation><nlm:aff id="aff5"><addr-line>Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Webby, Richard J" sort="Webby, Richard J" uniqKey="Webby R" first="Richard J." last="Webby">Richard J. Webby</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff6"><addr-line>St. Jude Center of Excellence for Influenza Research and Surveillance, Memphis, Tennessee, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff7"><addr-line>Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Shaw Saliba, Kathryn" sort="Shaw Saliba, Kathryn" uniqKey="Shaw Saliba K" first="Kathryn" last="Shaw-Saliba">Kathryn Shaw-Saliba</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff8"><addr-line>Johns Hopkins Center of Excellence for Influenza Research and Surveillance, Baltimore, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff9"><addr-line>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff10"><addr-line>W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wan, Hongquan" sort="Wan, Hongquan" uniqKey="Wan H" first="Hongquan" last="Wan">Hongquan Wan</name>
<affiliation><nlm:aff id="aff5"><addr-line>Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wilson, Patrick C" sort="Wilson, Patrick C" uniqKey="Wilson P" first="Patrick C." last="Wilson">Patrick C. Wilson</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff11"><addr-line>New York Influenza Center of Excellence (NYICE), New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff12"><addr-line>Department of Medicine, the Knapp Center for Lupus and Immunology Research, Section of Rheumatology, the University of Chicago, Chicago, Illinois, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Compans, Richard W" sort="Compans, Richard W" uniqKey="Compans R" first="Richard W." last="Compans">Richard W. Compans</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff13"><addr-line>Emory-UGA Center of Excellence for Influenza Research and Surveillance, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff14"><addr-line>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff15"><addr-line>Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Skountzou, Ioanna" sort="Skountzou, Ioanna" uniqKey="Skountzou I" first="Ioanna" last="Skountzou">Ioanna Skountzou</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff13"><addr-line>Emory-UGA Center of Excellence for Influenza Research and Surveillance, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff14"><addr-line>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff15"><addr-line>Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Monto, Arnold S" sort="Monto, Arnold S" uniqKey="Monto A" first="Arnold S." last="Monto">Arnold S. Monto</name>
<affiliation><nlm:aff id="aff3"><addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff11"><addr-line>New York Influenza Center of Excellence (NYICE), New York, New York, USA</addr-line>
</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="aff16"><addr-line>Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA</addr-line>
</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">mBio</title>
<idno type="eISSN">2150-7511</idno>
<imprint><date when="2018">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>ABSTRACT</title>
<p>Neuraminidase is one of the two surface glycoproteins of influenza A and B viruses. It has enzymatic activity that cleaves terminal sialic acid from glycans, and that activity is essential at several points in the virus life cycle. While neuraminidase is a major target for influenza antivirals, it is largely ignored in vaccine development. Current inactivated influenza virus vaccines might contain neuraminidase, but the antigen quantity and quality are varied and not standardized. While there are data that show a protective role of anti-neuraminidase immunity, many questions remain unanswered. These questions, among others, concern the targeted epitopes or antigenic sites, the potential for antigenic drift, and, connected to that, the breadth of protection, differences in induction of immune responses by vaccination versus infection, mechanisms of protection, the role of mucosal antineuraminidase antibodies, stability, and the immunogenicity of neuraminidase in vaccine formulations. Reagents for analysis of neuraminidase-based immunity are scarce, and assays are not widely used for clinical studies evaluating vaccines. However, efforts to better understand neuraminidase-based immunity have been made recently. A neuraminidase focus group, NAction!, was formed at a Centers of Excellence for Influenza Research and Surveillance meeting at the National Institutes of Health in Bethesda, MD, to promote research that helps to understand neuraminidase-based immunity and how it can contribute to the design of better and broadly protective influenza virus vaccines. Here, we review open questions and knowledge gaps that have been identified by this group and discuss how the gaps can be addressed, with the ultimate goal of designing better influenza virus vaccines.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Russell, Cj" uniqKey="Russell C">CJ Russell</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="De Graaf, M" uniqKey="De Graaf M">M de Graaf</name>
</author>
<author><name sortKey="Fouchier, Ra" uniqKey="Fouchier R">RA Fouchier</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Berlanda Scorza, F" uniqKey="Berlanda Scorza F">F Berlanda Scorza</name>
</author>
<author><name sortKey="Tsvetnitsky, V" uniqKey="Tsvetnitsky V">V Tsvetnitsky</name>
</author>
<author><name sortKey="Donnelly, Jj" uniqKey="Donnelly J">JJ Donnelly</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wohlbold, Tj" uniqKey="Wohlbold T">TJ Wohlbold</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
<author><name sortKey="Wan, H" uniqKey="Wan H">H Wan</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Cohen, M" uniqKey="Cohen M">M Cohen</name>
</author>
<author><name sortKey="Zhang, Xq" uniqKey="Zhang X">XQ Zhang</name>
</author>
<author><name sortKey="Senaati, Hp" uniqKey="Senaati H">HP Senaati</name>
</author>
<author><name sortKey="Chen, Hw" uniqKey="Chen H">HW Chen</name>
</author>
<author><name sortKey="Varki, Nm" uniqKey="Varki N">NM Varki</name>
</author>
<author><name sortKey="Schooley, Rt" uniqKey="Schooley R">RT Schooley</name>
</author>
<author><name sortKey="Gagneux, P" uniqKey="Gagneux P">P Gagneux</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Yang, X" uniqKey="Yang X">X Yang</name>
</author>
<author><name sortKey="Steukers, L" uniqKey="Steukers L">L Steukers</name>
</author>
<author><name sortKey="Forier, K" uniqKey="Forier K">K Forier</name>
</author>
<author><name sortKey="Xiong, R" uniqKey="Xiong R">R Xiong</name>
</author>
<author><name sortKey="Braeckmans, K" uniqKey="Braeckmans K">K Braeckmans</name>
</author>
<author><name sortKey="Van Reeth, K" uniqKey="Van Reeth K">K Van Reeth</name>
</author>
<author><name sortKey="Nauwynck, H" uniqKey="Nauwynck H">H Nauwynck</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Matrosovich, Mn" uniqKey="Matrosovich M">MN Matrosovich</name>
</author>
<author><name sortKey="Matrosovich, Ty" uniqKey="Matrosovich T">TY Matrosovich</name>
</author>
<author><name sortKey="Gray, T" uniqKey="Gray T">T Gray</name>
</author>
<author><name sortKey="Roberts, Na" uniqKey="Roberts N">NA Roberts</name>
</author>
<author><name sortKey="Klenk, Hd" uniqKey="Klenk H">HD Klenk</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Ma, J" uniqKey="Ma J">J Ma</name>
</author>
<author><name sortKey="Rubin, Bk" uniqKey="Rubin B">BK Rubin</name>
</author>
<author><name sortKey="Voynow, Ja" uniqKey="Voynow J">JA Voynow</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Matrosovich, Mn" uniqKey="Matrosovich M">MN Matrosovich</name>
</author>
<author><name sortKey="Matrosovich, Ty" uniqKey="Matrosovich T">TY Matrosovich</name>
</author>
<author><name sortKey="Gray, T" uniqKey="Gray T">T Gray</name>
</author>
<author><name sortKey="Roberts, Na" uniqKey="Roberts N">NA Roberts</name>
</author>
<author><name sortKey="Klenk, Hd" uniqKey="Klenk H">HD Klenk</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kilbourne, Ed" uniqKey="Kilbourne E">ED Kilbourne</name>
</author>
<author><name sortKey="Laver, Wg" uniqKey="Laver W">WG Laver</name>
</author>
<author><name sortKey="Schulman, Jl" uniqKey="Schulman J">JL Schulman</name>
</author>
<author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Su, B" uniqKey="Su B">B Su</name>
</author>
<author><name sortKey="Wurtzer, S" uniqKey="Wurtzer S">S Wurtzer</name>
</author>
<author><name sortKey="Rameix Welti, Ma" uniqKey="Rameix Welti M">MA Rameix-Welti</name>
</author>
<author><name sortKey="Dwyer, D" uniqKey="Dwyer D">D Dwyer</name>
</author>
<author><name sortKey="Van Der Werf, S" uniqKey="Van Der Werf S">S van der Werf</name>
</author>
<author><name sortKey="Naffakh, N" uniqKey="Naffakh N">N Naffakh</name>
</author>
<author><name sortKey="Clavel, F" uniqKey="Clavel F">F Clavel</name>
</author>
<author><name sortKey="Labrosse, B" uniqKey="Labrosse B">B Labrosse</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sakai, T" uniqKey="Sakai T">T Sakai</name>
</author>
<author><name sortKey="Nishimura, Si" uniqKey="Nishimura S">SI Nishimura</name>
</author>
<author><name sortKey="Naito, T" uniqKey="Naito T">T Naito</name>
</author>
<author><name sortKey="Saito, M" uniqKey="Saito M">M Saito</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Nguyen Van Tam, Js" uniqKey="Nguyen Van Tam J">JS Nguyen-Van-Tam</name>
</author>
<author><name sortKey="Venkatesan, S" uniqKey="Venkatesan S">S Venkatesan</name>
</author>
<author><name sortKey="Muthuri, Sg" uniqKey="Muthuri S">SG Muthuri</name>
</author>
<author><name sortKey="Myles, Pr" uniqKey="Myles P">PR Myles</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wohlbold, Tj" uniqKey="Wohlbold T">TJ Wohlbold</name>
</author>
<author><name sortKey="Podolsky, Ka" uniqKey="Podolsky K">KA Podolsky</name>
</author>
<author><name sortKey="Chromikova, V" uniqKey="Chromikova V">V Chromikova</name>
</author>
<author><name sortKey="Kirkpatrick, E" uniqKey="Kirkpatrick E">E Kirkpatrick</name>
</author>
<author><name sortKey="Falconieri, V" uniqKey="Falconieri V">V Falconieri</name>
</author>
<author><name sortKey="Meade, P" uniqKey="Meade P">P Meade</name>
</author>
<author><name sortKey="Amanat, F" uniqKey="Amanat F">F Amanat</name>
</author>
<author><name sortKey="Tan, J" uniqKey="Tan J">J Tan</name>
</author>
<author><name sortKey="Tenoever, Br" uniqKey="Tenoever B">BR tenOever</name>
</author>
<author><name sortKey="Tan, Gs" uniqKey="Tan G">GS Tan</name>
</author>
<author><name sortKey="Subramaniam, S" uniqKey="Subramaniam S">S Subramaniam</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Jiang, L" uniqKey="Jiang L">L Jiang</name>
</author>
<author><name sortKey="Fantoni, G" uniqKey="Fantoni G">G Fantoni</name>
</author>
<author><name sortKey="Couzens, L" uniqKey="Couzens L">L Couzens</name>
</author>
<author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Plant, E" uniqKey="Plant E">E Plant</name>
</author>
<author><name sortKey="Ye, Z" uniqKey="Ye Z">Z Ye</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
<author><name sortKey="Wan, H" uniqKey="Wan H">H Wan</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wan, H" uniqKey="Wan H">H Wan</name>
</author>
<author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Xu, K" uniqKey="Xu K">K Xu</name>
</author>
<author><name sortKey="Chen, H" uniqKey="Chen H">H Chen</name>
</author>
<author><name sortKey="Couzens, Lk" uniqKey="Couzens L">LK Couzens</name>
</author>
<author><name sortKey="Rivers, Kh" uniqKey="Rivers K">KH Rivers</name>
</author>
<author><name sortKey="Easterbrook, Jd" uniqKey="Easterbrook J">JD Easterbrook</name>
</author>
<author><name sortKey="Yang, K" uniqKey="Yang K">K Yang</name>
</author>
<author><name sortKey="Zhong, L" uniqKey="Zhong L">L Zhong</name>
</author>
<author><name sortKey="Rajabi, M" uniqKey="Rajabi M">M Rajabi</name>
</author>
<author><name sortKey="Ye, J" uniqKey="Ye J">J Ye</name>
</author>
<author><name sortKey="Sultana, I" uniqKey="Sultana I">I Sultana</name>
</author>
<author><name sortKey="Wan, Xf" uniqKey="Wan X">XF Wan</name>
</author>
<author><name sortKey="Liu, X" uniqKey="Liu X">X Liu</name>
</author>
<author><name sortKey="Perez, Dr" uniqKey="Perez D">DR Perez</name>
</author>
<author><name sortKey="Taubenberger, Jk" uniqKey="Taubenberger J">JK Taubenberger</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wohlbold, Tj" uniqKey="Wohlbold T">TJ Wohlbold</name>
</author>
<author><name sortKey="Chromikova, V" uniqKey="Chromikova V">V Chromikova</name>
</author>
<author><name sortKey="Tan, Gs" uniqKey="Tan G">GS Tan</name>
</author>
<author><name sortKey="Meade, P" uniqKey="Meade P">P Meade</name>
</author>
<author><name sortKey="Amanat, F" uniqKey="Amanat F">F Amanat</name>
</author>
<author><name sortKey="Comella, P" uniqKey="Comella P">P Comella</name>
</author>
<author><name sortKey="Hirsh, A" uniqKey="Hirsh A">A Hirsh</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Couzens, L" uniqKey="Couzens L">L Couzens</name>
</author>
<author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Westgeest, K" uniqKey="Westgeest K">K Westgeest</name>
</author>
<author><name sortKey="Sandbulte, M" uniqKey="Sandbulte M">M Sandbulte</name>
</author>
<author><name sortKey="Lugovtsev, V" uniqKey="Lugovtsev V">V Lugovtsev</name>
</author>
<author><name sortKey="Fouchier, R" uniqKey="Fouchier R">R Fouchier</name>
</author>
<author><name sortKey="Eichelberger, M" uniqKey="Eichelberger M">M Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schulman, Jl" uniqKey="Schulman J">JL Schulman</name>
</author>
<author><name sortKey="Khakpour, M" uniqKey="Khakpour M">M Khakpour</name>
</author>
<author><name sortKey="Kilbourne, Ed" uniqKey="Kilbourne E">ED Kilbourne</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Easterbrook, Jd" uniqKey="Easterbrook J">JD Easterbrook</name>
</author>
<author><name sortKey="Schwartzman, Lm" uniqKey="Schwartzman L">LM Schwartzman</name>
</author>
<author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Kash, Jc" uniqKey="Kash J">JC Kash</name>
</author>
<author><name sortKey="Morens, Dm" uniqKey="Morens D">DM Morens</name>
</author>
<author><name sortKey="Couzens, L" uniqKey="Couzens L">L Couzens</name>
</author>
<author><name sortKey="Wan, H" uniqKey="Wan H">H Wan</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
<author><name sortKey="Taubenberger, Jk" uniqKey="Taubenberger J">JK Taubenberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wohlbold, Tj" uniqKey="Wohlbold T">TJ Wohlbold</name>
</author>
<author><name sortKey="Nachbagauer, R" uniqKey="Nachbagauer R">R Nachbagauer</name>
</author>
<author><name sortKey="Xu, H" uniqKey="Xu H">H Xu</name>
</author>
<author><name sortKey="Tan, Gs" uniqKey="Tan G">GS Tan</name>
</author>
<author><name sortKey="Hirsh, A" uniqKey="Hirsh A">A Hirsh</name>
</author>
<author><name sortKey="Brokstad, Ka" uniqKey="Brokstad K">KA Brokstad</name>
</author>
<author><name sortKey="Cox, Rj" uniqKey="Cox R">RJ Cox</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Liu, Wc" uniqKey="Liu W">WC Liu</name>
</author>
<author><name sortKey="Lin, Cy" uniqKey="Lin C">CY Lin</name>
</author>
<author><name sortKey="Tsou, Yt" uniqKey="Tsou Y">YT Tsou</name>
</author>
<author><name sortKey="Jan, Jt" uniqKey="Jan J">JT Jan</name>
</author>
<author><name sortKey="Wu, Sc" uniqKey="Wu S">SC Wu</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Rockman, S" uniqKey="Rockman S">S Rockman</name>
</author>
<author><name sortKey="Brown, Le" uniqKey="Brown L">LE Brown</name>
</author>
<author><name sortKey="Barr, Ig" uniqKey="Barr I">IG Barr</name>
</author>
<author><name sortKey="Gilbertson, B" uniqKey="Gilbertson B">B Gilbertson</name>
</author>
<author><name sortKey="Lowther, S" uniqKey="Lowther S">S Lowther</name>
</author>
<author><name sortKey="Kachurin, A" uniqKey="Kachurin A">A Kachurin</name>
</author>
<author><name sortKey="Kachurina, O" uniqKey="Kachurina O">O Kachurina</name>
</author>
<author><name sortKey="Klippel, J" uniqKey="Klippel J">J Klippel</name>
</author>
<author><name sortKey="Bodle, J" uniqKey="Bodle J">J Bodle</name>
</author>
<author><name sortKey="Pearse, M" uniqKey="Pearse M">M Pearse</name>
</author>
<author><name sortKey="Middleton, D" uniqKey="Middleton D">D Middleton</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Smith, Ge" uniqKey="Smith G">GE Smith</name>
</author>
<author><name sortKey="Sun, X" uniqKey="Sun X">X Sun</name>
</author>
<author><name sortKey="Bai, Y" uniqKey="Bai Y">Y Bai</name>
</author>
<author><name sortKey="Liu, Yv" uniqKey="Liu Y">YV Liu</name>
</author>
<author><name sortKey="Massare, Mj" uniqKey="Massare M">MJ Massare</name>
</author>
<author><name sortKey="Pearce, Mb" uniqKey="Pearce M">MB Pearce</name>
</author>
<author><name sortKey="Belser, Ja" uniqKey="Belser J">JA Belser</name>
</author>
<author><name sortKey="Maines, Tr" uniqKey="Maines T">TR Maines</name>
</author>
<author><name sortKey="Creager, Hm" uniqKey="Creager H">HM Creager</name>
</author>
<author><name sortKey="Glenn, Gm" uniqKey="Glenn G">GM Glenn</name>
</author>
<author><name sortKey="Flyer, D" uniqKey="Flyer D">D Flyer</name>
</author>
<author><name sortKey="Pushko, P" uniqKey="Pushko P">P Pushko</name>
</author>
<author><name sortKey="Levine, Mz" uniqKey="Levine M">MZ Levine</name>
</author>
<author><name sortKey="Tumpey, Tm" uniqKey="Tumpey T">TM Tumpey</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Couch, Rb" uniqKey="Couch R">RB Couch</name>
</author>
<author><name sortKey="Kasel, Ja" uniqKey="Kasel J">JA Kasel</name>
</author>
<author><name sortKey="Gerin, Jl" uniqKey="Gerin J">JL Gerin</name>
</author>
<author><name sortKey="Schulman, Jl" uniqKey="Schulman J">JL Schulman</name>
</author>
<author><name sortKey="Kilbourne, Ed" uniqKey="Kilbourne E">ED Kilbourne</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Murphy, Br" uniqKey="Murphy B">BR Murphy</name>
</author>
<author><name sortKey="Kasel, Ja" uniqKey="Kasel J">JA Kasel</name>
</author>
<author><name sortKey="Chanock, Rm" uniqKey="Chanock R">RM Chanock</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Monto, As" uniqKey="Monto A">AS Monto</name>
</author>
<author><name sortKey="Petrie, Jg" uniqKey="Petrie J">JG Petrie</name>
</author>
<author><name sortKey="Cross, Rt" uniqKey="Cross R">RT Cross</name>
</author>
<author><name sortKey="Johnson, E" uniqKey="Johnson E">E Johnson</name>
</author>
<author><name sortKey="Liu, M" uniqKey="Liu M">M Liu</name>
</author>
<author><name sortKey="Zhong, W" uniqKey="Zhong W">W Zhong</name>
</author>
<author><name sortKey="Levine, M" uniqKey="Levine M">M Levine</name>
</author>
<author><name sortKey="Katz, Jm" uniqKey="Katz J">JM Katz</name>
</author>
<author><name sortKey="Ohmit, Se" uniqKey="Ohmit S">SE Ohmit</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Memoli, Mj" uniqKey="Memoli M">MJ Memoli</name>
</author>
<author><name sortKey="Shaw, Pa" uniqKey="Shaw P">PA Shaw</name>
</author>
<author><name sortKey="Han, A" uniqKey="Han A">A Han</name>
</author>
<author><name sortKey="Czajkowski, L" uniqKey="Czajkowski L">L Czajkowski</name>
</author>
<author><name sortKey="Reed, S" uniqKey="Reed S">S Reed</name>
</author>
<author><name sortKey="Athota, R" uniqKey="Athota R">R Athota</name>
</author>
<author><name sortKey="Bristol, T" uniqKey="Bristol T">T Bristol</name>
</author>
<author><name sortKey="Fargis, S" uniqKey="Fargis S">S Fargis</name>
</author>
<author><name sortKey="Risos, K" uniqKey="Risos K">K Risos</name>
</author>
<author><name sortKey="Powers, Jh" uniqKey="Powers J">JH Powers</name>
</author>
<author><name sortKey="Davey, Rt" uniqKey="Davey R">RT Davey</name>
</author>
<author><name sortKey="Taubenberger, Jk" uniqKey="Taubenberger J">JK Taubenberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schulman, Jl" uniqKey="Schulman J">JL Schulman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Monto, As" uniqKey="Monto A">AS Monto</name>
</author>
<author><name sortKey="Kendal, Ap" uniqKey="Kendal A">AP Kendal</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Wang, Tt" uniqKey="Wang T">TT Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sandbulte, Mr" uniqKey="Sandbulte M">MR Sandbulte</name>
</author>
<author><name sortKey="Westgeest, Kb" uniqKey="Westgeest K">KB Westgeest</name>
</author>
<author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Xu, X" uniqKey="Xu X">X Xu</name>
</author>
<author><name sortKey="Klimov, Ai" uniqKey="Klimov A">AI Klimov</name>
</author>
<author><name sortKey="Russell, Ca" uniqKey="Russell C">CA Russell</name>
</author>
<author><name sortKey="Burke, Df" uniqKey="Burke D">DF Burke</name>
</author>
<author><name sortKey="Smith, Dj" uniqKey="Smith D">DJ Smith</name>
</author>
<author><name sortKey="Fouchier, Ra" uniqKey="Fouchier R">RA Fouchier</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wan, H" uniqKey="Wan H">H Wan</name>
</author>
<author><name sortKey="Yang, H" uniqKey="Yang H">H Yang</name>
</author>
<author><name sortKey="Shore, Da" uniqKey="Shore D">DA Shore</name>
</author>
<author><name sortKey="Garten, Rj" uniqKey="Garten R">RJ Garten</name>
</author>
<author><name sortKey="Couzens, L" uniqKey="Couzens L">L Couzens</name>
</author>
<author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Jiang, L" uniqKey="Jiang L">L Jiang</name>
</author>
<author><name sortKey="Carney, Pj" uniqKey="Carney P">PJ Carney</name>
</author>
<author><name sortKey="Villanueva, J" uniqKey="Villanueva J">J Villanueva</name>
</author>
<author><name sortKey="Stevens, J" uniqKey="Stevens J">J Stevens</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Venkatramani, L" uniqKey="Venkatramani L">L Venkatramani</name>
</author>
<author><name sortKey="Bochkareva, E" uniqKey="Bochkareva E">E Bochkareva</name>
</author>
<author><name sortKey="Lee, Jt" uniqKey="Lee J">JT Lee</name>
</author>
<author><name sortKey="Gulati, U" uniqKey="Gulati U">U Gulati</name>
</author>
<author><name sortKey="Graeme Laver, W" uniqKey="Graeme Laver W">W Graeme Laver</name>
</author>
<author><name sortKey="Bochkarev, A" uniqKey="Bochkarev A">A Bochkarev</name>
</author>
<author><name sortKey="Air, Gm" uniqKey="Air G">GM Air</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Air, Gm" uniqKey="Air G">GM Air</name>
</author>
<author><name sortKey="Els, Mc" uniqKey="Els M">MC Els</name>
</author>
<author><name sortKey="Brown, Le" uniqKey="Brown L">LE Brown</name>
</author>
<author><name sortKey="Laver, Wg" uniqKey="Laver W">WG Laver</name>
</author>
<author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Colman, Pm" uniqKey="Colman P">PM Colman</name>
</author>
<author><name sortKey="Tulip, Wr" uniqKey="Tulip W">WR Tulip</name>
</author>
<author><name sortKey="Varghese, Jn" uniqKey="Varghese J">JN Varghese</name>
</author>
<author><name sortKey="Tulloch, Pa" uniqKey="Tulloch P">PA Tulloch</name>
</author>
<author><name sortKey="Baker, At" uniqKey="Baker A">AT Baker</name>
</author>
<author><name sortKey="Laver, Wg" uniqKey="Laver W">WG Laver</name>
</author>
<author><name sortKey="Air, Gm" uniqKey="Air G">GM Air</name>
</author>
<author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lee, Jt" uniqKey="Lee J">JT Lee</name>
</author>
<author><name sortKey="Air, Gm" uniqKey="Air G">GM Air</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lee, Jt" uniqKey="Lee J">JT Lee</name>
</author>
<author><name sortKey="Air, Gm" uniqKey="Air G">GM Air</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Nuss, Jm" uniqKey="Nuss J">JM Nuss</name>
</author>
<author><name sortKey="Whitaker, Pb" uniqKey="Whitaker P">PB Whitaker</name>
</author>
<author><name sortKey="Air, Gm" uniqKey="Air G">GM Air</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Johansson, Be" uniqKey="Johansson B">BE Johansson</name>
</author>
<author><name sortKey="Moran, Tm" uniqKey="Moran T">TM Moran</name>
</author>
<author><name sortKey="Kilbourne, Ed" uniqKey="Kilbourne E">ED Kilbourne</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Johansson, Be" uniqKey="Johansson B">BE Johansson</name>
</author>
<author><name sortKey="Kilbourne, Ed" uniqKey="Kilbourne E">ED Kilbourne</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kilbourne, Ed" uniqKey="Kilbourne E">ED Kilbourne</name>
</author>
<author><name sortKey="Couch, Rb" uniqKey="Couch R">RB Couch</name>
</author>
<author><name sortKey="Kasel, Ja" uniqKey="Kasel J">JA Kasel</name>
</author>
<author><name sortKey="Keitel, Wa" uniqKey="Keitel W">WA Keitel</name>
</author>
<author><name sortKey="Cate, Tr" uniqKey="Cate T">TR Cate</name>
</author>
<author><name sortKey="Quarles, Jh" uniqKey="Quarles J">JH Quarles</name>
</author>
<author><name sortKey="Grajower, B" uniqKey="Grajower B">B Grajower</name>
</author>
<author><name sortKey="Pokorny, Ba" uniqKey="Pokorny B">BA Pokorny</name>
</author>
<author><name sortKey="Johansson, Be" uniqKey="Johansson B">BE Johansson</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Nachbagauer, R" uniqKey="Nachbagauer R">R Nachbagauer</name>
</author>
<author><name sortKey="Wohlbold, Tj" uniqKey="Wohlbold T">TJ Wohlbold</name>
</author>
<author><name sortKey="Hirsh, A" uniqKey="Hirsh A">A Hirsh</name>
</author>
<author><name sortKey="Hai, R" uniqKey="Hai R">R Hai</name>
</author>
<author><name sortKey="Sjursen, H" uniqKey="Sjursen H">H Sjursen</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Cox, Rj" uniqKey="Cox R">RJ Cox</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Powers, Dc" uniqKey="Powers D">DC Powers</name>
</author>
<author><name sortKey="Kilbourne, Ed" uniqKey="Kilbourne E">ED Kilbourne</name>
</author>
<author><name sortKey="Johansson, Be" uniqKey="Johansson B">BE Johansson</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Laguio Vila, Mr" uniqKey="Laguio Vila M">MR Laguio-Vila</name>
</author>
<author><name sortKey="Thompson, Mg" uniqKey="Thompson M">MG Thompson</name>
</author>
<author><name sortKey="Reynolds, S" uniqKey="Reynolds S">S Reynolds</name>
</author>
<author><name sortKey="Spencer, Sm" uniqKey="Spencer S">SM Spencer</name>
</author>
<author><name sortKey="Gaglani, M" uniqKey="Gaglani M">M Gaglani</name>
</author>
<author><name sortKey="Naleway, A" uniqKey="Naleway A">A Naleway</name>
</author>
<author><name sortKey="Ball, S" uniqKey="Ball S">S Ball</name>
</author>
<author><name sortKey="Bozeman, S" uniqKey="Bozeman S">S Bozeman</name>
</author>
<author><name sortKey="Baker, S" uniqKey="Baker S">S Baker</name>
</author>
<author><name sortKey="Martinez Sobrido, L" uniqKey="Martinez Sobrido L">L Martínez-Sobrido</name>
</author>
<author><name sortKey="Levine, M" uniqKey="Levine M">M Levine</name>
</author>
<author><name sortKey="Katz, J" uniqKey="Katz J">J Katz</name>
</author>
<author><name sortKey="Fry, Am" uniqKey="Fry A">AM Fry</name>
</author>
<author><name sortKey="Treanor, Jj" uniqKey="Treanor J">JJ Treanor</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Couch, Rb" uniqKey="Couch R">RB Couch</name>
</author>
<author><name sortKey="Atmar, Rl" uniqKey="Atmar R">RL Atmar</name>
</author>
<author><name sortKey="Keitel, Wa" uniqKey="Keitel W">WA Keitel</name>
</author>
<author><name sortKey="Quarles, Jm" uniqKey="Quarles J">JM Quarles</name>
</author>
<author><name sortKey="Wells, J" uniqKey="Wells J">J Wells</name>
</author>
<author><name sortKey="Arden, N" uniqKey="Arden N">N Arden</name>
</author>
<author><name sortKey="Ni O, D" uniqKey="Ni O D">D Niño</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hassantoufighi, A" uniqKey="Hassantoufighi A">A Hassantoufighi</name>
</author>
<author><name sortKey="Zhang, H" uniqKey="Zhang H">H Zhang</name>
</author>
<author><name sortKey="Sandbulte, M" uniqKey="Sandbulte M">M Sandbulte</name>
</author>
<author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Manischewitz, J" uniqKey="Manischewitz J">J Manischewitz</name>
</author>
<author><name sortKey="King, L" uniqKey="King L">L King</name>
</author>
<author><name sortKey="Golding, H" uniqKey="Golding H">H Golding</name>
</author>
<author><name sortKey="Straight, Tm" uniqKey="Straight T">TM Straight</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Cate, Tr" uniqKey="Cate T">TR Cate</name>
</author>
<author><name sortKey="Rayford, Y" uniqKey="Rayford Y">Y Rayford</name>
</author>
<author><name sortKey="Ni O, D" uniqKey="Ni O D">D Niño</name>
</author>
<author><name sortKey="Winokur, P" uniqKey="Winokur P">P Winokur</name>
</author>
<author><name sortKey="Brady, R" uniqKey="Brady R">R Brady</name>
</author>
<author><name sortKey="Belshe, R" uniqKey="Belshe R">R Belshe</name>
</author>
<author><name sortKey="Chen, W" uniqKey="Chen W">W Chen</name>
</author>
<author><name sortKey="Atmar, Rl" uniqKey="Atmar R">RL Atmar</name>
</author>
<author><name sortKey="Couch, Rb" uniqKey="Couch R">RB Couch</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Couch, Rb" uniqKey="Couch R">RB Couch</name>
</author>
<author><name sortKey="Atmar, Rl" uniqKey="Atmar R">RL Atmar</name>
</author>
<author><name sortKey="Franco, Lm" uniqKey="Franco L">LM Franco</name>
</author>
<author><name sortKey="Quarles, Jm" uniqKey="Quarles J">JM Quarles</name>
</author>
<author><name sortKey="Wells, J" uniqKey="Wells J">J Wells</name>
</author>
<author><name sortKey="Arden, N" uniqKey="Arden N">N Arden</name>
</author>
<author><name sortKey="Ni O, D" uniqKey="Ni O D">D Niño</name>
</author>
<author><name sortKey="Belmont, Jw" uniqKey="Belmont J">JW Belmont</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Getie Kebtie, M" uniqKey="Getie Kebtie M">M Getie-Kebtie</name>
</author>
<author><name sortKey="Sultana, I" uniqKey="Sultana I">I Sultana</name>
</author>
<author><name sortKey="Eichelberger, M" uniqKey="Eichelberger M">M Eichelberger</name>
</author>
<author><name sortKey="Alterman, M" uniqKey="Alterman M">M Alterman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sultana, I" uniqKey="Sultana I">I Sultana</name>
</author>
<author><name sortKey="Yang, K" uniqKey="Yang K">K Yang</name>
</author>
<author><name sortKey="Getie Kebtie, M" uniqKey="Getie Kebtie M">M Getie-Kebtie</name>
</author>
<author><name sortKey="Couzens, L" uniqKey="Couzens L">L Couzens</name>
</author>
<author><name sortKey="Markoff, L" uniqKey="Markoff L">L Markoff</name>
</author>
<author><name sortKey="Alterman, M" uniqKey="Alterman M">M Alterman</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Van Der Velden, Mv" uniqKey="Van Der Velden M">MV van der Velden</name>
</author>
<author><name sortKey="Fritz, R" uniqKey="Fritz R">R Fritz</name>
</author>
<author><name sortKey="Pollabauer, Em" uniqKey="Pollabauer E">EM Pöllabauer</name>
</author>
<author><name sortKey="Portsmouth, D" uniqKey="Portsmouth D">D Portsmouth</name>
</author>
<author><name sortKey="Howard, Mk" uniqKey="Howard M">MK Howard</name>
</author>
<author><name sortKey="Kreil, Tr" uniqKey="Kreil T">TR Kreil</name>
</author>
<author><name sortKey="Dvorak, T" uniqKey="Dvorak T">T Dvorak</name>
</author>
<author><name sortKey="Fritsch, S" uniqKey="Fritsch S">S Fritsch</name>
</author>
<author><name sortKey="Vesikari, T" uniqKey="Vesikari T">T Vesikari</name>
</author>
<author><name sortKey="Diez Domingo, J" uniqKey="Diez Domingo J">J Diez-Domingo</name>
</author>
<author><name sortKey="Richmond, P" uniqKey="Richmond P">P Richmond</name>
</author>
<author><name sortKey="Lee, Bw" uniqKey="Lee B">BW Lee</name>
</author>
<author><name sortKey="Kistner, O" uniqKey="Kistner O">O Kistner</name>
</author>
<author><name sortKey="Ehrlich, Hj" uniqKey="Ehrlich H">HJ Ehrlich</name>
</author>
<author><name sortKey="Barrett, Pn" uniqKey="Barrett P">PN Barrett</name>
</author>
<author><name sortKey="Aichinger, G" uniqKey="Aichinger G">G Aichinger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Ben Yehuda, A" uniqKey="Ben Yehuda A">A Ben-Yehuda</name>
</author>
<author><name sortKey="Joseph, A" uniqKey="Joseph A">A Joseph</name>
</author>
<author><name sortKey="Barenholz, Y" uniqKey="Barenholz Y">Y Barenholz</name>
</author>
<author><name sortKey="Zeira, E" uniqKey="Zeira E">E Zeira</name>
</author>
<author><name sortKey="Even Chen, S" uniqKey="Even Chen S">S Even-Chen</name>
</author>
<author><name sortKey="Louria Hayon, I" uniqKey="Louria Hayon I">I Louria-Hayon</name>
</author>
<author><name sortKey="Babai, I" uniqKey="Babai I">I Babai</name>
</author>
<author><name sortKey="Zakay Rones, Z" uniqKey="Zakay Rones Z">Z Zakay-Rones</name>
</author>
<author><name sortKey="Greenbaum, E" uniqKey="Greenbaum E">E Greenbaum</name>
</author>
<author><name sortKey="Galprin, I" uniqKey="Galprin I">I Galprin</name>
</author>
<author><name sortKey="Gluck, R" uniqKey="Gluck R">R Glück</name>
</author>
<author><name sortKey="Zurbriggen, R" uniqKey="Zurbriggen R">R Zurbriggen</name>
</author>
<author><name sortKey="Kedar, E" uniqKey="Kedar E">E Kedar</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Johansson, Be" uniqKey="Johansson B">BE Johansson</name>
</author>
<author><name sortKey="Matthews, Jt" uniqKey="Matthews J">JT Matthews</name>
</author>
<author><name sortKey="Kilbourne, Ed" uniqKey="Kilbourne E">ED Kilbourne</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Dalakouras, T" uniqKey="Dalakouras T">T Dalakouras</name>
</author>
<author><name sortKey="Smith, Bj" uniqKey="Smith B">BJ Smith</name>
</author>
<author><name sortKey="Platis, D" uniqKey="Platis D">D Platis</name>
</author>
<author><name sortKey="Cox, Mm" uniqKey="Cox M">MM Cox</name>
</author>
<author><name sortKey="Labrou, Ne" uniqKey="Labrou N">NE Labrou</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schiff, Gke" uniqKey="Schiff G">GKE Schiff</name>
</author>
<author><name sortKey="Smith, G" uniqKey="Smith G">G Smith</name>
</author>
<author><name sortKey="Hackett, C" uniqKey="Hackett C">C Hackett</name>
</author>
<author><name sortKey="Manoff, S" uniqKey="Manoff S">S Manoff</name>
</author>
<author><name sortKey="Matthews, J" uniqKey="Matthews J">J Matthews</name>
</author>
<author><name sortKey="Johansson, B" uniqKey="Johansson B">B Johansson</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Halbherr, Sj" uniqKey="Halbherr S">SJ Halbherr</name>
</author>
<author><name sortKey="Ludersdorfer, Th" uniqKey="Ludersdorfer T">TH Ludersdorfer</name>
</author>
<author><name sortKey="Ricklin, M" uniqKey="Ricklin M">M Ricklin</name>
</author>
<author><name sortKey="Locher, S" uniqKey="Locher S">S Locher</name>
</author>
<author><name sortKey="Berger Rentsch, M" uniqKey="Berger Rentsch M">M Berger Rentsch</name>
</author>
<author><name sortKey="Summerfield, A" uniqKey="Summerfield A">A Summerfield</name>
</author>
<author><name sortKey="Zimmer, G" uniqKey="Zimmer G">G Zimmer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Doyle, Tm" uniqKey="Doyle T">TM Doyle</name>
</author>
<author><name sortKey="Hashem, Am" uniqKey="Hashem A">AM Hashem</name>
</author>
<author><name sortKey="Li, C" uniqKey="Li C">C Li</name>
</author>
<author><name sortKey="Van Domselaar, G" uniqKey="Van Domselaar G">G Van Domselaar</name>
</author>
<author><name sortKey="Larocque, L" uniqKey="Larocque L">L Larocque</name>
</author>
<author><name sortKey="Wang, J" uniqKey="Wang J">J Wang</name>
</author>
<author><name sortKey="Smith, D" uniqKey="Smith D">D Smith</name>
</author>
<author><name sortKey="Cyr, T" uniqKey="Cyr T">T Cyr</name>
</author>
<author><name sortKey="Farnsworth, A" uniqKey="Farnsworth A">A Farnsworth</name>
</author>
<author><name sortKey="He, R" uniqKey="He R">R He</name>
</author>
<author><name sortKey="Hurt, Ac" uniqKey="Hurt A">AC Hurt</name>
</author>
<author><name sortKey="Brown, Eg" uniqKey="Brown E">EG Brown</name>
</author>
<author><name sortKey="Li, X" uniqKey="Li X">X Li</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Doyle, Tm" uniqKey="Doyle T">TM Doyle</name>
</author>
<author><name sortKey="Li, C" uniqKey="Li C">C Li</name>
</author>
<author><name sortKey="Bucher, Dj" uniqKey="Bucher D">DJ Bucher</name>
</author>
<author><name sortKey="Hashem, Am" uniqKey="Hashem A">AM Hashem</name>
</author>
<author><name sortKey="Van Domselaar, G" uniqKey="Van Domselaar G">G Van Domselaar</name>
</author>
<author><name sortKey="Wang, J" uniqKey="Wang J">J Wang</name>
</author>
<author><name sortKey="Farnsworth, A" uniqKey="Farnsworth A">A Farnsworth</name>
</author>
<author><name sortKey="She, Ym" uniqKey="She Y">YM She</name>
</author>
<author><name sortKey="Cyr, T" uniqKey="Cyr T">T Cyr</name>
</author>
<author><name sortKey="He, R" uniqKey="He R">R He</name>
</author>
<author><name sortKey="Brown, Eg" uniqKey="Brown E">EG Brown</name>
</author>
<author><name sortKey="Hurt, Ac" uniqKey="Hurt A">AC Hurt</name>
</author>
<author><name sortKey="Li, X" uniqKey="Li X">X Li</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kilbourne, Ed" uniqKey="Kilbourne E">ED Kilbourne</name>
</author>
<author><name sortKey="Johansson, Be" uniqKey="Johansson B">BE Johansson</name>
</author>
<author><name sortKey="Grajower, B" uniqKey="Grajower B">B Grajower</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Westgeest, Kb" uniqKey="Westgeest K">KB Westgeest</name>
</author>
<author><name sortKey="Bestebroer, Tm" uniqKey="Bestebroer T">TM Bestebroer</name>
</author>
<author><name sortKey="Spronken, Mi" uniqKey="Spronken M">MI Spronken</name>
</author>
<author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Couzens, L" uniqKey="Couzens L">L Couzens</name>
</author>
<author><name sortKey="Osterhaus, Ad" uniqKey="Osterhaus A">AD Osterhaus</name>
</author>
<author><name sortKey="Eichelberger, M" uniqKey="Eichelberger M">M Eichelberger</name>
</author>
<author><name sortKey="Fouchier, Ra" uniqKey="Fouchier R">RA Fouchier</name>
</author>
<author><name sortKey="De Graaf, M" uniqKey="De Graaf M">M de Graaf</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Rajendran, M" uniqKey="Rajendran M">M Rajendran</name>
</author>
<author><name sortKey="Nachbagauer, R" uniqKey="Nachbagauer R">R Nachbagauer</name>
</author>
<author><name sortKey="Ermler, Me" uniqKey="Ermler M">ME Ermler</name>
</author>
<author><name sortKey="Bunduc, P" uniqKey="Bunduc P">P Bunduc</name>
</author>
<author><name sortKey="Amanat, F" uniqKey="Amanat F">F Amanat</name>
</author>
<author><name sortKey="Izikson, R" uniqKey="Izikson R">R Izikson</name>
</author>
<author><name sortKey="Cox, M" uniqKey="Cox M">M Cox</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Eichelberger, M" uniqKey="Eichelberger M">M Eichelberger</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Nachbagauer, R" uniqKey="Nachbagauer R">R Nachbagauer</name>
</author>
<author><name sortKey="Choi, A" uniqKey="Choi A">A Choi</name>
</author>
<author><name sortKey="Hirsh, A" uniqKey="Hirsh A">A Hirsh</name>
</author>
<author><name sortKey="Margine, I" uniqKey="Margine I">I Margine</name>
</author>
<author><name sortKey="Iida, S" uniqKey="Iida S">S Iida</name>
</author>
<author><name sortKey="Barrera, A" uniqKey="Barrera A">A Barrera</name>
</author>
<author><name sortKey="Ferres, M" uniqKey="Ferres M">M Ferres</name>
</author>
<author><name sortKey="Albrecht, Ra" uniqKey="Albrecht R">RA Albrecht</name>
</author>
<author><name sortKey="Garcia Sastre, A" uniqKey="Garcia Sastre A">A García-Sastre</name>
</author>
<author><name sortKey="Bouvier, Nm" uniqKey="Bouvier N">NM Bouvier</name>
</author>
<author><name sortKey="Ito, K" uniqKey="Ito K">K Ito</name>
</author>
<author><name sortKey="Medina, Ra" uniqKey="Medina R">RA Medina</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Mohr, Pg" uniqKey="Mohr P">PG Mohr</name>
</author>
<author><name sortKey="Deng, Ym" uniqKey="Deng Y">YM Deng</name>
</author>
<author><name sortKey="Mckimm Breschkin, Jl" uniqKey="Mckimm Breschkin J">JL McKimm-Breschkin</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lin, Yp" uniqKey="Lin Y">YP Lin</name>
</author>
<author><name sortKey="Gregory, V" uniqKey="Gregory V">V Gregory</name>
</author>
<author><name sortKey="Collins, P" uniqKey="Collins P">P Collins</name>
</author>
<author><name sortKey="Kloess, J" uniqKey="Kloess J">J Kloess</name>
</author>
<author><name sortKey="Wharton, S" uniqKey="Wharton S">S Wharton</name>
</author>
<author><name sortKey="Cattle, N" uniqKey="Cattle N">N Cattle</name>
</author>
<author><name sortKey="Lackenby, A" uniqKey="Lackenby A">A Lackenby</name>
</author>
<author><name sortKey="Daniels, R" uniqKey="Daniels R">R Daniels</name>
</author>
<author><name sortKey="Hay, A" uniqKey="Hay A">A Hay</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Mogling, R" uniqKey="Mogling R">R Mögling</name>
</author>
<author><name sortKey="Richard, Mj" uniqKey="Richard M">MJ Richard</name>
</author>
<author><name sortKey="Vliet, Sv" uniqKey="Vliet S">SV Vliet</name>
</author>
<author><name sortKey="Beek, Rv" uniqKey="Beek R">RV Beek</name>
</author>
<author><name sortKey="Schrauwen, Eja" uniqKey="Schrauwen E">EJA Schrauwen</name>
</author>
<author><name sortKey="Spronken, Mi" uniqKey="Spronken M">MI Spronken</name>
</author>
<author><name sortKey="Rimmelzwaan, Gf" uniqKey="Rimmelzwaan G">GF Rimmelzwaan</name>
</author>
<author><name sortKey="Fouchier, Ram" uniqKey="Fouchier R">RAM Fouchier</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Dilillo, Dj" uniqKey="Dilillo D">DJ Dilillo</name>
</author>
<author><name sortKey="Tan, Gs" uniqKey="Tan G">GS Tan</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Ravetch, Jv" uniqKey="Ravetch J">JV Ravetch</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Jegaskanda, S" uniqKey="Jegaskanda S">S Jegaskanda</name>
</author>
<author><name sortKey="Reading, Pc" uniqKey="Reading P">PC Reading</name>
</author>
<author><name sortKey="Kent, Sj" uniqKey="Kent S">SJ Kent</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="De Vries, Rd" uniqKey="De Vries R">RD de Vries</name>
</author>
<author><name sortKey="Nieuwkoop, Nj" uniqKey="Nieuwkoop N">NJ Nieuwkoop</name>
</author>
<author><name sortKey="Van Der Klis, Frm" uniqKey="Van Der Klis F">FRM van der Klis</name>
</author>
<author><name sortKey="Koopmans, Mpg" uniqKey="Koopmans M">MPG Koopmans</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
<author><name sortKey="Rimmelzwaan, Gf" uniqKey="Rimmelzwaan G">GF Rimmelzwaan</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="De Vries, Rd" uniqKey="De Vries R">RD de Vries</name>
</author>
<author><name sortKey="Nieuwkoop, Nj" uniqKey="Nieuwkoop N">NJ Nieuwkoop</name>
</author>
<author><name sortKey="Pronk, M" uniqKey="Pronk M">M Pronk</name>
</author>
<author><name sortKey="De Bruin, E" uniqKey="De Bruin E">E de Bruin</name>
</author>
<author><name sortKey="Leroux Roels, G" uniqKey="Leroux Roels G">G Leroux-Roels</name>
</author>
<author><name sortKey="Huijskens, Egw" uniqKey="Huijskens E">EGW Huijskens</name>
</author>
<author><name sortKey="Van Binnendijk, Rs" uniqKey="Van Binnendijk R">RS van Binnendijk</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
<author><name sortKey="Koopmans, Mpg" uniqKey="Koopmans M">MPG Koopmans</name>
</author>
<author><name sortKey="Rimmelzwaan, Gf" uniqKey="Rimmelzwaan G">GF Rimmelzwaan</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Leon, Pe" uniqKey="Leon P">PE Leon</name>
</author>
<author><name sortKey="He, W" uniqKey="He W">W He</name>
</author>
<author><name sortKey="Mullarkey, Ce" uniqKey="Mullarkey C">CE Mullarkey</name>
</author>
<author><name sortKey="Bailey, Mj" uniqKey="Bailey M">MJ Bailey</name>
</author>
<author><name sortKey="Miller, Ms" uniqKey="Miller M">MS Miller</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Tan, Gs" uniqKey="Tan G">GS Tan</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Cox, F" uniqKey="Cox F">F Cox</name>
</author>
<author><name sortKey="Kwaks, T" uniqKey="Kwaks T">T Kwaks</name>
</author>
<author><name sortKey="Brandenburg, B" uniqKey="Brandenburg B">B Brandenburg</name>
</author>
<author><name sortKey="Koldijk, Mh" uniqKey="Koldijk M">MH Koldijk</name>
</author>
<author><name sortKey="Klaren, V" uniqKey="Klaren V">V Klaren</name>
</author>
<author><name sortKey="Smal, B" uniqKey="Smal B">B Smal</name>
</author>
<author><name sortKey="Korse, Hj" uniqKey="Korse H">HJ Korse</name>
</author>
<author><name sortKey="Geelen, E" uniqKey="Geelen E">E Geelen</name>
</author>
<author><name sortKey="Tettero, L" uniqKey="Tettero L">L Tettero</name>
</author>
<author><name sortKey="Zuijdgeest, D" uniqKey="Zuijdgeest D">D Zuijdgeest</name>
</author>
<author><name sortKey="Stoop, Ej" uniqKey="Stoop E">EJ Stoop</name>
</author>
<author><name sortKey="Saeland, E" uniqKey="Saeland E">E Saeland</name>
</author>
<author><name sortKey="Vogels, R" uniqKey="Vogels R">R Vogels</name>
</author>
<author><name sortKey="Friesen, Rh" uniqKey="Friesen R">RH Friesen</name>
</author>
<author><name sortKey="Koudstaal, W" uniqKey="Koudstaal W">W Koudstaal</name>
</author>
<author><name sortKey="Goudsmit, J" uniqKey="Goudsmit J">J Goudsmit</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="He, W" uniqKey="He W">W He</name>
</author>
<author><name sortKey="Tan, Gs" uniqKey="Tan G">GS Tan</name>
</author>
<author><name sortKey="Mullarkey, Ce" uniqKey="Mullarkey C">CE Mullarkey</name>
</author>
<author><name sortKey="Lee, Aj" uniqKey="Lee A">AJ Lee</name>
</author>
<author><name sortKey="Lam, Mm" uniqKey="Lam M">MM Lam</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
<author><name sortKey="Henry, C" uniqKey="Henry C">C Henry</name>
</author>
<author><name sortKey="Wilson, Pc" uniqKey="Wilson P">PC Wilson</name>
</author>
<author><name sortKey="Ashkar, Aa" uniqKey="Ashkar A">AA Ashkar</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Miller, Ms" uniqKey="Miller M">MS Miller</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bar On, Y" uniqKey="Bar On Y">Y Bar-On</name>
</author>
<author><name sortKey="Glasner, A" uniqKey="Glasner A">A Glasner</name>
</author>
<author><name sortKey="Meningher, T" uniqKey="Meningher T">T Meningher</name>
</author>
<author><name sortKey="Achdout, H" uniqKey="Achdout H">H Achdout</name>
</author>
<author><name sortKey="Gur, C" uniqKey="Gur C">C Gur</name>
</author>
<author><name sortKey="Lankry, D" uniqKey="Lankry D">D Lankry</name>
</author>
<author><name sortKey="Vitenshtein, A" uniqKey="Vitenshtein A">A Vitenshtein</name>
</author>
<author><name sortKey="Meyers, Afa" uniqKey="Meyers A">AFA Meyers</name>
</author>
<author><name sortKey="Mandelboim, M" uniqKey="Mandelboim M">M Mandelboim</name>
</author>
<author><name sortKey="Mandelboim, O" uniqKey="Mandelboim O">O Mandelboim</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bar On, Y" uniqKey="Bar On Y">Y Bar-On</name>
</author>
<author><name sortKey="Seidel, E" uniqKey="Seidel E">E Seidel</name>
</author>
<author><name sortKey="Tsukerman, P" uniqKey="Tsukerman P">P Tsukerman</name>
</author>
<author><name sortKey="Mandelboim, M" uniqKey="Mandelboim M">M Mandelboim</name>
</author>
<author><name sortKey="Mandelboim, O" uniqKey="Mandelboim O">O Mandelboim</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hurwitz, Jl" uniqKey="Hurwitz J">JL Hurwitz</name>
</author>
<author><name sortKey="Hackett, Cj" uniqKey="Hackett C">CJ Hackett</name>
</author>
<author><name sortKey="Mcandrew, Ec" uniqKey="Mcandrew E">EC McAndrew</name>
</author>
<author><name sortKey="Gerhard, W" uniqKey="Gerhard W">W Gerhard</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hackett, Cj" uniqKey="Hackett C">CJ Hackett</name>
</author>
<author><name sortKey="Horowitz, D" uniqKey="Horowitz D">D Horowitz</name>
</author>
<author><name sortKey="Wysocka, M" uniqKey="Wysocka M">M Wysocka</name>
</author>
<author><name sortKey="Eisenlohr, Lc" uniqKey="Eisenlohr L">LC Eisenlohr</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Carlson, Cm" uniqKey="Carlson C">CM Carlson</name>
</author>
<author><name sortKey="Turpin, Ea" uniqKey="Turpin E">EA Turpin</name>
</author>
<author><name sortKey="Moser, La" uniqKey="Moser L">LA Moser</name>
</author>
<author><name sortKey="O Rien, Kb" uniqKey="O Rien K">KB O’Brien</name>
</author>
<author><name sortKey="Cline, Td" uniqKey="Cline T">TD Cline</name>
</author>
<author><name sortKey="Jones, Jc" uniqKey="Jones J">JC Jones</name>
</author>
<author><name sortKey="Tumpey, Tm" uniqKey="Tumpey T">TM Tumpey</name>
</author>
<author><name sortKey="Katz, Jm" uniqKey="Katz J">JM Katz</name>
</author>
<author><name sortKey="Kelley, La" uniqKey="Kelley L">LA Kelley</name>
</author>
<author><name sortKey="Gauldie, J" uniqKey="Gauldie J">J Gauldie</name>
</author>
<author><name sortKey="Schultz Cherry, S" uniqKey="Schultz Cherry S">S Schultz-Cherry</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schultz Cherry, S" uniqKey="Schultz Cherry S">S Schultz-Cherry</name>
</author>
<author><name sortKey="Hinshaw, Vs" uniqKey="Hinshaw V">VS Hinshaw</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Oh, S" uniqKey="Oh S">S Oh</name>
</author>
<author><name sortKey="Belz, Gt" uniqKey="Belz G">GT Belz</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Oh, S" uniqKey="Oh S">S Oh</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Oh, S" uniqKey="Oh S">S Oh</name>
</author>
<author><name sortKey="Mccaffery, Jm" uniqKey="Mccaffery J">JM McCaffery</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Babiuk, S" uniqKey="Babiuk S">S Babiuk</name>
</author>
<author><name sortKey="Skowronski, Dm" uniqKey="Skowronski D">DM Skowronski</name>
</author>
<author><name sortKey="De Serres, G" uniqKey="De Serres G">G De Serres</name>
</author>
<author><name sortKey="Hayglass, K" uniqKey="Hayglass K">K HayGlass</name>
</author>
<author><name sortKey="Brunham, Rc" uniqKey="Brunham R">RC Brunham</name>
</author>
<author><name sortKey="Babiuk, L" uniqKey="Babiuk L">L Babiuk</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wan, H" uniqKey="Wan H">H Wan</name>
</author>
<author><name sortKey="Sultana, I" uniqKey="Sultana I">I Sultana</name>
</author>
<author><name sortKey="Couzens, Lk" uniqKey="Couzens L">LK Couzens</name>
</author>
<author><name sortKey="Mindaye, S" uniqKey="Mindaye S">S Mindaye</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kuck, Lr" uniqKey="Kuck L">LR Kuck</name>
</author>
<author><name sortKey="Saye, S" uniqKey="Saye S">S Saye</name>
</author>
<author><name sortKey="Loob, S" uniqKey="Loob S">S Loob</name>
</author>
<author><name sortKey="Roth Eichhorn, S" uniqKey="Roth Eichhorn S">S Roth-Eichhorn</name>
</author>
<author><name sortKey="Byrne Nash, R" uniqKey="Byrne Nash R">R Byrne-Nash</name>
</author>
<author><name sortKey="Rowlen, Kl" uniqKey="Rowlen K">KL Rowlen</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Solano, Mi" uniqKey="Solano M">MI Solano</name>
</author>
<author><name sortKey="Woolfitt, Ar" uniqKey="Woolfitt A">AR Woolfitt</name>
</author>
<author><name sortKey="Williams, Tl" uniqKey="Williams T">TL Williams</name>
</author>
<author><name sortKey="Pierce, Cl" uniqKey="Pierce C">CL Pierce</name>
</author>
<author><name sortKey="Gubareva, Lv" uniqKey="Gubareva L">LV Gubareva</name>
</author>
<author><name sortKey="Mishin, V" uniqKey="Mishin V">V Mishin</name>
</author>
<author><name sortKey="Barr, Jr" uniqKey="Barr J">JR Barr</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bouvier, Nm" uniqKey="Bouvier N">NM Bouvier</name>
</author>
<author><name sortKey="Lowen, Ac" uniqKey="Lowen A">AC Lowen</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Couzens, L" uniqKey="Couzens L">L Couzens</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sandbulte, Mr" uniqKey="Sandbulte M">MR Sandbulte</name>
</author>
<author><name sortKey="Gao, J" uniqKey="Gao J">J Gao</name>
</author>
<author><name sortKey="Straight, Tm" uniqKey="Straight T">TM Straight</name>
</author>
<author><name sortKey="Eichelberger, Mc" uniqKey="Eichelberger M">MC Eichelberger</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Jacobsen, H" uniqKey="Jacobsen H">H Jacobsen</name>
</author>
<author><name sortKey="Rajendran, M" uniqKey="Rajendran M">M Rajendran</name>
</author>
<author><name sortKey="Choi, A" uniqKey="Choi A">A Choi</name>
</author>
<author><name sortKey="Sjursen, H" uniqKey="Sjursen H">H Sjursen</name>
</author>
<author><name sortKey="Brokstad, Ka" uniqKey="Brokstad K">KA Brokstad</name>
</author>
<author><name sortKey="Cox, Rj" uniqKey="Cox R">RJ Cox</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
<author><name sortKey="Nachbagauer, R" uniqKey="Nachbagauer R">R Nachbagauer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Gavrilov, V" uniqKey="Gavrilov V">V Gavrilov</name>
</author>
<author><name sortKey="Orekov, T" uniqKey="Orekov T">T Orekov</name>
</author>
<author><name sortKey="Alabanza, C" uniqKey="Alabanza C">C Alabanza</name>
</author>
<author><name sortKey="Porika, U" uniqKey="Porika U">U Porika</name>
</author>
<author><name sortKey="Jiang, H" uniqKey="Jiang H">H Jiang</name>
</author>
<author><name sortKey="Connolly, K" uniqKey="Connolly K">K Connolly</name>
</author>
<author><name sortKey="Pincus, S" uniqKey="Pincus S">S Pincus</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Prevato, M" uniqKey="Prevato M">M Prevato</name>
</author>
<author><name sortKey="Ferlenghi, I" uniqKey="Ferlenghi I">I Ferlenghi</name>
</author>
<author><name sortKey="Bonci, A" uniqKey="Bonci A">A Bonci</name>
</author>
<author><name sortKey="Uematsu, Y" uniqKey="Uematsu Y">Y Uematsu</name>
</author>
<author><name sortKey="Anselmi, G" uniqKey="Anselmi G">G Anselmi</name>
</author>
<author><name sortKey="Giusti, F" uniqKey="Giusti F">F Giusti</name>
</author>
<author><name sortKey="Bertholet, S" uniqKey="Bertholet S">S Bertholet</name>
</author>
<author><name sortKey="Legay, F" uniqKey="Legay F">F Legay</name>
</author>
<author><name sortKey="Telford, Jl" uniqKey="Telford J">JL Telford</name>
</author>
<author><name sortKey="Settembre, Ec" uniqKey="Settembre E">EC Settembre</name>
</author>
<author><name sortKey="Maione, D" uniqKey="Maione D">D Maione</name>
</author>
<author><name sortKey="Cozzi, R" uniqKey="Cozzi R">R Cozzi</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schotsaert, M" uniqKey="Schotsaert M">M Schotsaert</name>
</author>
<author><name sortKey="Ysenbaert, T" uniqKey="Ysenbaert T">T Ysenbaert</name>
</author>
<author><name sortKey="Smet, A" uniqKey="Smet A">A Smet</name>
</author>
<author><name sortKey="Schepens, B" uniqKey="Schepens B">B Schepens</name>
</author>
<author><name sortKey="Vanderschaeghe, D" uniqKey="Vanderschaeghe D">D Vanderschaeghe</name>
</author>
<author><name sortKey="Stegalkina, S" uniqKey="Stegalkina S">S Stegalkina</name>
</author>
<author><name sortKey="Vogel, Tu" uniqKey="Vogel T">TU Vogel</name>
</author>
<author><name sortKey="Callewaert, N" uniqKey="Callewaert N">N Callewaert</name>
</author>
<author><name sortKey="Fiers, W" uniqKey="Fiers W">W Fiers</name>
</author>
<author><name sortKey="Saelens, X" uniqKey="Saelens X">X Saelens</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kosik, I" uniqKey="Kosik I">I Kosik</name>
</author>
<author><name sortKey="Yewdell, Jw" uniqKey="Yewdell J">JW Yewdell</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Prevato, M" uniqKey="Prevato M">M Prevato</name>
</author>
<author><name sortKey="Cozzi, R" uniqKey="Cozzi R">R Cozzi</name>
</author>
<author><name sortKey="Pezzicoli, A" uniqKey="Pezzicoli A">A Pezzicoli</name>
</author>
<author><name sortKey="Taddei, Ar" uniqKey="Taddei A">AR Taddei</name>
</author>
<author><name sortKey="Ferlenghi, I" uniqKey="Ferlenghi I">I Ferlenghi</name>
</author>
<author><name sortKey="Nandi, A" uniqKey="Nandi A">A Nandi</name>
</author>
<author><name sortKey="Montomoli, E" uniqKey="Montomoli E">E Montomoli</name>
</author>
<author><name sortKey="Settembre, Ec" uniqKey="Settembre E">EC Settembre</name>
</author>
<author><name sortKey="Bertholet, S" uniqKey="Bertholet S">S Bertholet</name>
</author>
<author><name sortKey="Bonci, A" uniqKey="Bonci A">A Bonci</name>
</author>
<author><name sortKey="Legay, F" uniqKey="Legay F">F Legay</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Margine, I" uniqKey="Margine I">I Margine</name>
</author>
<author><name sortKey="Palese, P" uniqKey="Palese P">P Palese</name>
</author>
<author><name sortKey="Krammer, F" uniqKey="Krammer F">F Krammer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schmidt, Pm" uniqKey="Schmidt P">PM Schmidt</name>
</author>
<author><name sortKey="Attwood, Rm" uniqKey="Attwood R">RM Attwood</name>
</author>
<author><name sortKey="Mohr, Pg" uniqKey="Mohr P">PG Mohr</name>
</author>
<author><name sortKey="Barrett, Sa" uniqKey="Barrett S">SA Barrett</name>
</author>
<author><name sortKey="Mckimm Breschkin, Jl" uniqKey="Mckimm Breschkin J">JL McKimm-Breschkin</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Xu, X" uniqKey="Xu X">X Xu</name>
</author>
<author><name sortKey="Zhu, X" uniqKey="Zhu X">X Zhu</name>
</author>
<author><name sortKey="Dwek, Ra" uniqKey="Dwek R">RA Dwek</name>
</author>
<author><name sortKey="Stevens, J" uniqKey="Stevens J">J Stevens</name>
</author>
<author><name sortKey="Wilson, Ia" uniqKey="Wilson I">IA Wilson</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Paules, Ci" uniqKey="Paules C">CI Paules</name>
</author>
<author><name sortKey="Marston, Hd" uniqKey="Marston H">HD Marston</name>
</author>
<author><name sortKey="Eisinger, Rw" uniqKey="Eisinger R">RW Eisinger</name>
</author>
<author><name sortKey="Baltimore, D" uniqKey="Baltimore D">D Baltimore</name>
</author>
<author><name sortKey="Fauci, As" uniqKey="Fauci A">AS Fauci</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Zhu, X" uniqKey="Zhu X">X Zhu</name>
</author>
<author><name sortKey="Mcbride, R" uniqKey="Mcbride R">R McBride</name>
</author>
<author><name sortKey="Nycholat, Cm" uniqKey="Nycholat C">CM Nycholat</name>
</author>
<author><name sortKey="Yu, W" uniqKey="Yu W">W Yu</name>
</author>
<author><name sortKey="Paulson, Jc" uniqKey="Paulson J">JC Paulson</name>
</author>
<author><name sortKey="Wilson, Ia" uniqKey="Wilson I">IA Wilson</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">mBio</journal-id>
<journal-id journal-id-type="iso-abbrev">MBio</journal-id>
<journal-id journal-id-type="hwp">mbio</journal-id>
<journal-id journal-id-type="pmc">mbio</journal-id>
<journal-id journal-id-type="publisher-id">mBio</journal-id>
<journal-title-group><journal-title>mBio</journal-title>
</journal-title-group>
<issn pub-type="epub">2150-7511</issn>
<publisher><publisher-name>American Society for Microbiology</publisher-name>
<publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">29615508</article-id>
<article-id pub-id-type="pmc">5885027</article-id>
<article-id pub-id-type="publisher-id">mBio02332-17</article-id>
<article-id pub-id-type="doi">10.1128/mBio.02332-17</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Minireview</subject>
</subj-group>
</article-categories>
<title-group><article-title>NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?</article-title>
<alt-title alt-title-type="running-head">Minireview</alt-title>
</title-group>
<contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4121-776X</contrib-id>
<name><surname>Krammer</surname>
<given-names>Florian</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2"><sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3"><sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Fouchier</surname>
<given-names>Ron A. M.</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3"><sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff4"><sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Eichelberger</surname>
<given-names>Maryna C.</given-names>
</name>
<xref ref-type="aff" rid="aff5"><sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Webby</surname>
<given-names>Richard J.</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff6"><sup>f</sup>
</xref>
<xref ref-type="aff" rid="aff7"><sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Shaw-Saliba</surname>
<given-names>Kathryn</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff8"><sup>h</sup>
</xref>
<xref ref-type="aff" rid="aff9"><sup>i</sup>
</xref>
<xref ref-type="aff" rid="aff10"><sup>j</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Wan</surname>
<given-names>Hongquan</given-names>
</name>
<xref ref-type="aff" rid="aff5"><sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Wilson</surname>
<given-names>Patrick C.</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff11"><sup>k</sup>
</xref>
<xref ref-type="aff" rid="aff12"><sup>l</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Compans</surname>
<given-names>Richard W.</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff13"><sup>m</sup>
</xref>
<xref ref-type="aff" rid="aff14"><sup>n</sup>
</xref>
<xref ref-type="aff" rid="aff15"><sup>o</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Skountzou</surname>
<given-names>Ioanna</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff13"><sup>m</sup>
</xref>
<xref ref-type="aff" rid="aff14"><sup>n</sup>
</xref>
<xref ref-type="aff" rid="aff15"><sup>o</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Monto</surname>
<given-names>Arnold S.</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff11"><sup>k</sup>
</xref>
<xref ref-type="aff" rid="aff16"><sup>p</sup>
</xref>
</contrib>
<aff id="aff1"><label>a</label>
<addr-line>Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA</addr-line>
</aff>
<aff id="aff2"><label>b</label>
<addr-line>Icahn School of Medicine at Mount Sinai, New York, New York, USA</addr-line>
</aff>
<aff id="aff3"><label>c</label>
<addr-line>Centers of Excellence for Influenza Research and Surveillance (CEIRS)</addr-line>
<xref ref-type="author-notes" rid="fn1">‡</xref>
</aff>
<aff id="aff4"><label>d</label>
<addr-line>Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands</addr-line>
</aff>
<aff id="aff5"><label>e</label>
<addr-line>Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA</addr-line>
</aff>
<aff id="aff6"><label>f</label>
<addr-line>St. Jude Center of Excellence for Influenza Research and Surveillance, Memphis, Tennessee, USA</addr-line>
</aff>
<aff id="aff7"><label>g</label>
<addr-line>Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA</addr-line>
</aff>
<aff id="aff8"><label>h</label>
<addr-line>Johns Hopkins Center of Excellence for Influenza Research and Surveillance, Baltimore, Maryland, USA</addr-line>
</aff>
<aff id="aff9"><label>i</label>
<addr-line>Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</addr-line>
</aff>
<aff id="aff10"><label>j</label>
<addr-line>W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA</addr-line>
</aff>
<aff id="aff11"><label>k</label>
<addr-line>New York Influenza Center of Excellence (NYICE), New York, New York, USA</addr-line>
</aff>
<aff id="aff12"><label>l</label>
<addr-line>Department of Medicine, the Knapp Center for Lupus and Immunology Research, Section of Rheumatology, the University of Chicago, Chicago, Illinois, USA</addr-line>
</aff>
<aff id="aff13"><label>m</label>
<addr-line>Emory-UGA Center of Excellence for Influenza Research and Surveillance, Atlanta, Georgia, USA</addr-line>
</aff>
<aff id="aff14"><label>n</label>
<addr-line>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</aff>
<aff id="aff15"><label>o</label>
<addr-line>Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA</addr-line>
</aff>
<aff id="aff16"><label>p</label>
<addr-line>Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA</addr-line>
</aff>
</contrib-group>
<contrib-group><contrib contrib-type="editor"><name><surname>Garsin</surname>
<given-names>Danielle A.</given-names>
</name>
<role>Editor</role>
<aff>University of Texas Health Science Center at Houston</aff>
</contrib>
</contrib-group>
<author-notes><corresp id="cor1">Address correspondence to Florian Krammer, <email>florian.krammer@mssm.edu</email>
.</corresp>
<fn id="fn1" fn-type="other"><label>‡</label>
<p>For this virtual institution, see <ext-link ext-link-type="uri" xlink:href="http://www.niaidceirs.org/">http://www.niaidceirs.org/</ext-link>
.</p>
</fn>
</author-notes>
<pub-date pub-type="epub"><day>3</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection"><season>Mar-Apr</season>
<year>2018</year>
</pub-date>
<volume>9</volume>
<issue>2</issue>
<elocation-id>e02332-17</elocation-id>
<permissions><copyright-statement>Copyright © 2018 Krammer et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Krammer et al.</copyright-holder>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>
.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="mbo002183836001.pdf"></self-uri>
<abstract><title>ABSTRACT</title>
<p>Neuraminidase is one of the two surface glycoproteins of influenza A and B viruses. It has enzymatic activity that cleaves terminal sialic acid from glycans, and that activity is essential at several points in the virus life cycle. While neuraminidase is a major target for influenza antivirals, it is largely ignored in vaccine development. Current inactivated influenza virus vaccines might contain neuraminidase, but the antigen quantity and quality are varied and not standardized. While there are data that show a protective role of anti-neuraminidase immunity, many questions remain unanswered. These questions, among others, concern the targeted epitopes or antigenic sites, the potential for antigenic drift, and, connected to that, the breadth of protection, differences in induction of immune responses by vaccination versus infection, mechanisms of protection, the role of mucosal antineuraminidase antibodies, stability, and the immunogenicity of neuraminidase in vaccine formulations. Reagents for analysis of neuraminidase-based immunity are scarce, and assays are not widely used for clinical studies evaluating vaccines. However, efforts to better understand neuraminidase-based immunity have been made recently. A neuraminidase focus group, NAction!, was formed at a Centers of Excellence for Influenza Research and Surveillance meeting at the National Institutes of Health in Bethesda, MD, to promote research that helps to understand neuraminidase-based immunity and how it can contribute to the design of better and broadly protective influenza virus vaccines. Here, we review open questions and knowledge gaps that have been identified by this group and discuss how the gaps can be addressed, with the ultimate goal of designing better influenza virus vaccines.</p>
</abstract>
<kwd-group><title>KEYWORDS</title>
<kwd>influenza vaccines</kwd>
<kwd>neuraminidase</kwd>
<kwd>universal influenza virus vaccine</kwd>
</kwd-group>
<funding-group><award-group id="award1"><funding-source><institution-wrap><institution>BARDA</institution>
</institution-wrap>
</funding-source>
<award-id>HHSO100201500033C</award-id>
<principal-award-recipient><name><surname>Fouchier</surname>
<given-names>Ron A. M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award2"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>HHSN272201400008C</award-id>
<principal-award-recipient><name><surname>Krammer</surname>
<given-names>Florian</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award3"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>HHSN272201400008C</award-id>
<principal-award-recipient><name><surname>Fouchier</surname>
<given-names>Ron A. M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award4"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>HHSN272201400007C</award-id>
<principal-award-recipient><name><surname>Shaw-Saliba</surname>
<given-names>Kathryn</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award5"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>HHSN272201400006C</award-id>
<principal-award-recipient><name><surname>Webby</surname>
<given-names>Richard J.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award6"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>HHSN272201400005C</award-id>
<principal-award-recipient><name><surname>Wilson</surname>
<given-names>Patrick</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award7"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>HHSN272201400004C</award-id>
<principal-award-recipient><name><surname>Skountzou</surname>
<given-names>Ioanna</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award8"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>HHSN272201400004C</award-id>
<principal-award-recipient><name><surname>Compans</surname>
<given-names>Richard W.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award9"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>AI117287</award-id>
<principal-award-recipient><name><surname>Krammer</surname>
<given-names>Florian</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award10"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>AI109946</award-id>
<principal-award-recipient><name><surname>Wilson</surname>
<given-names>Patrick</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award11"><funding-source><institution-wrap><institution>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
<institution-id>https://doi.org/10.13039/100000060</institution-id>
</institution-wrap>
</funding-source>
<award-id>AI097150</award-id>
<principal-award-recipient><name><surname>Monto</surname>
<given-names>Arnold</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<counts><fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="102"></ref-count>
<page-count count="12"></page-count>
<word-count count="9550"></word-count>
</counts>
<custom-meta-group><custom-meta><meta-name>cover-date</meta-name>
<meta-value>March/April 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body><sec sec-type="intro" id="s0"><title>INTRODUCTION</title>
<p>Influenza A and B viruses express two surface glycoproteins which have essential functions in the viral life cycle. The more abundant glycoprotein is the hemagglutinin (HA), a type I transmembrane protein. HA exists as a trimer and mediates binding of the virus to host cells via interactions between its receptor binding site and the terminal sialic acids on host cell glycans. Once the virus is taken up into the endosome, HA also triggers fusion of viral and endosomal membranes after endosome acidification (<xref rid="B1" ref-type="bibr">1</xref>
, <xref rid="B2" ref-type="bibr">2</xref>
). Many antibodies that target the HA are neutralizing because they block the ability of the receptor binding site of HA to interact with sialic acids on the host cell surface, thus preventing attachment and entry. Because protection was classically recognized to be related to anti-HA antibodies, currently licensed vaccines are designed to induce antibodies against HA (<xref rid="B3" ref-type="bibr">3</xref>
). The development of better, more broadly protective vaccines is also mostly focused on the HA (<xref rid="B4" ref-type="bibr">4</xref>
). However, the second surface glycoprotein, neuraminidase (NA), might also play a key role in the development of a better influenza virus vaccine. NA is a tetrameric type II transmembrane protein with an enzymatic function that cleaves terminal sialic acid from glycans on the host cell surface, a process termed receptor-destroying activity (<xref rid="B5" ref-type="bibr">5</xref>
, <xref rid="B6" ref-type="bibr">6</xref>
) (see <xref ref-type="fig" rid="fig1">Fig. 1</xref>
for an overview). This activity is very important at several stages of the viral life cycle. As influenza viruses enter a host, they need to penetrate mucosal barriers in order for HA to reach the sialic acids on the host cell surface (<xref rid="B7" ref-type="bibr">7</xref>
<xref ref-type="bibr" rid="B8">–</xref>
<xref rid="B9" ref-type="bibr">9</xref>
). Further, mucosal fluids contain natural defense proteins, such as mucins, that are heavily glycosylated, acting as a decoy for HA binding, which neutralizes the influenza virus (<xref rid="B10" ref-type="bibr">10</xref>
). NA, however, has been shown to release virus particles and allow them to efficiently reach their host cells (<xref rid="B7" ref-type="bibr">7</xref>
, <xref rid="B8" ref-type="bibr">8</xref>
, <xref rid="B11" ref-type="bibr">11</xref>
). Once a virus has successfully entered and replicated in the host cell, virus particles containing both HA and NA bud from the cell membrane. As the host cell surface contains sialic acid, HA of nascent virus particles adheres to the same host cell, preventing the release of the new particle. However, NA counteracts this by removing terminal sialic acids from the host cell, thus allowing the release of the nascent viral particles (<xref rid="B12" ref-type="bibr">12</xref>
). Finally, viral particles adhere to each other by interactions between HA and sialic acid on glycans on HA or via other glycoproteins in mucus that act as adapters. NA counteracts this aggregation and might consequently enhance the spread and perhaps transmissibility of the newly produced virus through this activity by increasing the opportunity for virus particles to be transmitted in very small aerosol droplets (<xref rid="B6" ref-type="bibr">6</xref>
). In addition, NA might play a role in viral entry as well (<xref rid="B13" ref-type="bibr">13</xref>
, <xref rid="B14" ref-type="bibr">14</xref>
). NA activity is therefore very important for virus fitness and has been the target of licensed small-molecule drugs, like oseltamivir (<xref rid="B15" ref-type="bibr">15</xref>
). The fact that inhibition of NA activity has a prophylactic and therapeutic effect validates NA as a target. However, NA has largely been ignored for vaccine development. A better understanding of NA-based immunity and its mechanisms of action might greatly contribute to the design of better, longer-lasting, and more broadly protective vaccines. In this position paper, the NAction! group, an NA focus group that was recently formed at a meeting of the Centers of Excellence for Influenza Research and Surveillance (CEIRS; funded by the National Institute of Allergy and Infectious Diseases) in Bethesda, MD, tries to identify the gaps in knowledge about NA immunity and its protective effects and lays out a path forward to address them.</p>
<fig id="fig1" orientation="portrait" position="float"><label>FIG 1 </label>
<caption><p>Influenza virus neuraminidase structure and phylogeny. (A) Top-down view of the NA tetramer, with one of the monomers indicated in gray. (B) Side view of the molecule. The structure of the variable stalk domain has so far not been solved and is indicated by the 4 bars. Panels A and B are based on the structure of the N2 NA of A/Tanzania/205/2010 (PDB number <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/4GZO" assigning-authority="pdb">4GZO</ext-link>
[<xref rid="B102" ref-type="bibr">102</xref>
]), visualized in PyMOL (Schrödinger, Inc.). (C) Tree of known influenza virus NAs and NA-like proteins (N10 and N11). Influenza NAs cluster into group 1 (N1, N4, N5, N8) and group 2 NAs (N2, N3, N6, N7, N9). Influenza B NAs as well as the NA-like proteins (from sequences found in bats) form their own clusters. The tree was generated using Clustal Omega and was visualized in FigTree. The scale bar represents a 7% amino acid difference. NA sequences from the following strains were used: A/California/04/2009 (N1-Cal09), A/New Caledonia/20/1999 (N1-NC99), A/Puerto Rico/8/1934 (N1-PR8), A/Vietnam/1203/2004 (N1-H5N1), A/Michigan/45/2015 (N1-Mi15), A/Brevig Mission/1/1918 (N1-1918), A/Hong Kong/1/1968 (N2-HK68), A/Hong Kong/4801/2014 (N2-HK14), A/Singapore/1/1957 (N2-Sing57), A/chicken/Hong Kong/G9/1997 (N2-H9N2), A/Philippines/2/1982 (N2-Phil82), A/Beijing/353/1989 (N2-BJ89), A/Perth/16/2009 (N2-Perth09), A/swine/Missouri/4296424/2006 (N3), A/mallard/Sweden/24/2002 (N4), A/mallard/Sweden/86/2003 (N5), A/Caspian seal/Russia/T1/2012 (N6), A/harbor seal/Germany/1/2014 (N7), A/Jiangxi-Donghu/346/2013 (N8), A/Hong Kong/125/2017 (N9), A/yellow-shouldered bat/Guatemala/060/2010 (N10), A/bat/Peru/33/2010 (N11), B/Lee/1940 (Lee40), B/Florida/04/2006 (Flor06), B/Malaysia/2506/2004 (Mal04).</p>
</caption>
<graphic xlink:href="mbo0021838360001"></graphic>
</fig>
</sec>
<sec id="s1"><title>WHAT DO WE KNOW ABOUT NEURAMINIDASE-BASED IMMUNITY?</title>
<p>As outlined above, NA plays an important role in the virus life cycle, and targeting this protein by antibodies inhibits virus replication. NA antibodies are usually not capable of inhibiting virus entry into host cells but act at later stages of the life cycle when the virus buds from infected cells. As a result, plaque size and number are not reduced when NA-specific antibodies are included during infection in an <italic>in vitro</italic>
plaque reduction neutralization assay. However, plaque size (diameter) is impacted when these antibodies are included in the agar overlay of the assay (<xref rid="B16" ref-type="bibr">16</xref>
<xref ref-type="bibr" rid="B17">–</xref>
<xref rid="B19" ref-type="bibr">19</xref>
). Antibodies that inhibit NA activity at low concentrations are so effective in preventing virus spread that plaques are often not visible. Technically speaking, this means that most anti-NA antibodies are not capable of completely neutralizing the virus <italic>in vitro</italic>
. However, it is well known that many anti-NA antibodies can inhibit the enzymatic activity of NA in <italic>in vitro</italic>
NA inhibition (NI) assays (<xref rid="B20" ref-type="bibr">20</xref>
), and this activity usually correlates well with a reduction of plaque size, as discussed above (<xref rid="B17" ref-type="bibr">17</xref>
). We also know that the induction of a strong antibody response against NA in animal models can prevent clinically overt disease, while often not leading to sterilizing immunity (<xref rid="B21" ref-type="bibr">21</xref>
<xref ref-type="bibr" rid="B22">–</xref>
<xref rid="B26" ref-type="bibr">26</xref>
). From human challenge studies performed in the 1970s, we know that anti-NA antibody titers correlate inversely with virus shedding and disease symptoms (<xref rid="B27" ref-type="bibr">27</xref>
, <xref rid="B28" ref-type="bibr">28</xref>
). This means that virus replication is controlled and that no clinical disease is observed, but low-level virus replication is typically present. More recent clinical trials showed that NI titers are a correlate of protection against influenza virus-induced disease that is independent of HA-based immunity (<xref rid="B29" ref-type="bibr">29</xref>
). This was further confirmed in direct human challenge studies (<xref rid="B30" ref-type="bibr">30</xref>
). It is possible that N2-based immunity (induced by previous H2N2 infections) might have played a role in protecting subjects from pandemic H3N2 infections in 1968 (<xref rid="B28" ref-type="bibr">28</xref>
, <xref rid="B31" ref-type="bibr">31</xref>
, <xref rid="B32" ref-type="bibr">32</xref>
). N2-based cross-reactivity has even been implied to be a factor in the extinction of H2N2 in 1968 after the emergence of H3N2 (<xref rid="B33" ref-type="bibr">33</xref>
). We also know that NA undergoes evolution and can antigenically drift (<xref rid="B34" ref-type="bibr">34</xref>
), but we have very limited knowledge about antigenic sites/epitopes that might be targeted by the immune system (<xref rid="B16" ref-type="bibr">16</xref>
, <xref rid="B18" ref-type="bibr">18</xref>
, <xref rid="B35" ref-type="bibr">35</xref>
<xref ref-type="bibr" rid="B36">–</xref>
<xref rid="B41" ref-type="bibr">41</xref>
). Vaccines which contain HA and NA in close association may not induce anti-NA (<xref rid="B42" ref-type="bibr">42</xref>
) responses that are as strong as those induced by NA given on its own (<xref rid="B23" ref-type="bibr">23</xref>
, <xref rid="B24" ref-type="bibr">24</xref>
, <xref rid="B43" ref-type="bibr">43</xref>
, <xref rid="B44" ref-type="bibr">44</xref>
). Finally, we know that current inactivated influenza virus vaccines contain NA of variable quality and (nonstandardized) quantity, potentially with lot-to-lot variability, and these vaccines do not reliably induce robust anti-NA immunity (<xref rid="B23" ref-type="bibr">23</xref>
, <xref rid="B34" ref-type="bibr">34</xref>
, <xref rid="B45" ref-type="bibr">45</xref>
<xref ref-type="bibr" rid="B46">–</xref>
<xref rid="B48" ref-type="bibr">48</xref>
). Nevertheless, some increases in NI antibody responses, although at low seroconversion rates and with a low fold induction, have been reported for most inactivated virus vaccines and for live attenuated influenza virus vaccines (LAIV), and the response rate and antibody titers are increased by vaccinating with high-dose formulations (<xref rid="B48" ref-type="bibr">48</xref>
<xref ref-type="bibr" rid="B49">–</xref>
<xref rid="B50" ref-type="bibr">50</xref>
). This information, together with the finding that HA inhibition (HI) and NI titers correlate with protection against influenza virus infection independently (<xref rid="B29" ref-type="bibr">29</xref>
, <xref rid="B51" ref-type="bibr">51</xref>
), shows not only that NA-based immunity is important but also that it is feasible to develop vaccines that produce consistently protective NA-specific antibodies. To conclude, we have evidence that NA-based immunity can be important and protective. However, there are many knowledge gaps that need to be addressed in order to move forward toward a rationally designed vaccine that induces robust and protective anti-NA immunity.</p>
</sec>
<sec id="s2"><title>WHAT DO WE NEED TO KNOW?</title>
<p>In order to close the current knowledge gaps, assess the role that NA-based immunity might play in protection from influenza virus infection, and design vaccines that induce robust anti-NA responses, the following actions should be taken.</p>
<sec id="s2.1"><title>NA-based protection.</title>
<p>As mentioned above, studies by Couch et al. (<xref rid="B27" ref-type="bibr">27</xref>
, <xref rid="B51" ref-type="bibr">51</xref>
), Murphy et al. (<xref rid="B28" ref-type="bibr">28</xref>
), Monto et al. (<xref rid="B29" ref-type="bibr">29</xref>
), and Memoli et al. (<xref rid="B30" ref-type="bibr">30</xref>
) have shown that anti-NA antibody titers correlate with protection from disease in humans. These studies need to be expanded, the results need to be confirmed across H1N1, H3N2, and influenza B viruses for different age groups (which have different preexposure histories, etc.) and study designs, and the titers that correlate with protection need to be defined. Considering that NA antibodies control the spread of virus to and from epithelial cells, it will be important to understand the contribution of NA-specific immunity at mucosal surfaces. Also, the antigenic drift of NA should be studied in this context.</p>
</sec>
<sec id="s2.2"><title>Imprinting.</title>
<p>The phenomenon of immunologic imprinting and how it shapes immune responses to influenza virus HAs later in life is currently a major research focus. Imprinting should also be studied for NA, ideally by following subjects longitudinally from birth to determine how their immunity to NA is shaped by initial and sequential exposures to influenza virus and vaccines.</p>
</sec>
<sec id="s2.3"><title>Target epitopes.</title>
<p>Our understanding of which epitopes are targeted by human antibodies is limited at best. Human monoclonal antibodies induced by both vaccination and infection should be isolated and characterized. Antigenic sites need to be defined, and antibody footprints should be confirmed by structural biology methods.</p>
</sec>
<sec id="s2.4"><title>NA quality and quantity in vaccines.</title>
<p>Inactivated vaccines contain NAs of varied quality and quantity (<xref rid="B23" ref-type="bibr">23</xref>
, <xref rid="B52" ref-type="bibr">52</xref>
). Very little is known about the stability of NA during the production process and over the shelf life of vaccines. NA activity is representative of the native structure and is an excellent measure of the ability of NA to induce NI antibodies as long as NA inhibitors (e.g., EDTA) are not present in the vaccine formulation (<xref rid="B53" ref-type="bibr">53</xref>
). While a preliminary study suggests that NA activity might be maintained over vaccine shelf-lives for seasonal vaccines, the levels of stability of NAs from different strains vary (<xref rid="B53" ref-type="bibr">53</xref>
). The NA quantity in currently licensed vaccines is insufficiently quantified and not standardized in the United States. However, new vaccine platforms are considering the NA content of pandemic vaccines, and NA immunogenicity is being measured in clinical trials more often (<xref rid="B54" ref-type="bibr">54</xref>
, <xref rid="B55" ref-type="bibr">55</xref>
). Our understanding of NA immunogenicity would be greatly advanced if the NA contents of seasonal and pandemic vaccines were a required measure for batches used in clinical trials, and this should certainly be done in the future. It is important to make assays and reagents for these quantifications widely available (within and beyond the CEIRS network).</p>
</sec>
<sec id="s2.5"><title>Better vaccine formulations and strategies.</title>
<p>We already know that current inactivated vaccines induce varied anti-NA responses (approximately 30% seroconversion) (<xref rid="B23" ref-type="bibr">23</xref>
, <xref rid="B34" ref-type="bibr">34</xref>
, <xref rid="B45" ref-type="bibr">45</xref>
<xref ref-type="bibr" rid="B46">–</xref>
<xref rid="B48" ref-type="bibr">48</xref>
). New vaccine formulations and strategies that induce a more robust anti-NA immune response should be developed and tested in clinical trials. This could include spiking the regular inactivated vaccines with purified NA or giving purified NA in addition to current vaccines (<xref rid="B3" ref-type="bibr">3</xref>
, <xref rid="B56" ref-type="bibr">56</xref>
). A clinical trial with NA purified from H3N2 virions demonstrated that NA is safe and immunogenic, with a dose of 7.7 µg inducing a 3-fold or greater increase in NI antibody titers in 70% of vaccine recipients (<xref rid="B44" ref-type="bibr">44</xref>
). Modern methods for producing sufficient amounts of good manufacturing practice (GMP)-grade recombinant NA have been developed (<xref rid="B57" ref-type="bibr">57</xref>
). So far, one clinical trial evaluating trivalent inactivated vaccines (TIV) spiked with recombinant N2 followed by an H3N2 challenge has been performed. The results were reported in a conference abstract and describe a positive outcome of this study, but the results have not been published in a peer-reviewed journal (<xref rid="B58" ref-type="bibr">58</xref>
). Additional clinical trials that evaluate NA-only vaccines or NA-spiked inactivated vaccines are urgently needed to find formulations that induce optimal anti-NA immunity. Importantly, no GMP-produced purified NA antigen is currently available, and it will be needed for clinical trials.</p>
</sec>
<sec id="s2.6"><title>Is correctly folded, functional NA required to induce protective immune responses?</title>
<p>Whether functional NA is required to induce protective immune responses is connected to the previous point. Sultana et al. have observed that there is a correlation between the enzymatic activity (as a proxy of correct folding) of NA in vaccines and its ability to induce NI antibody responses (<xref rid="B53" ref-type="bibr">53</xref>
). Several anti-NA monoclonal antibodies (MAbs) that have been isolated and were found to be protective in animal models have been shown to bind to conformational epitopes as well (<xref rid="B16" ref-type="bibr">16</xref>
). However, this is not completely clear, and it might be possible to induce protective anti-NA responses with denatured NA. In turn, we assume that the antibody response is best measured using structurally intact NA, but other reagents, even peptides, might be useful to measure protective antibody responses in some cases. This is a very important point, and further research is needed to clarify this question.</p>
</sec>
<sec id="s2.7"><title>Breadth of the anti-NA response.</title>
<p>A considerable breadth of both monoclonal and polyclonal antibody responses against NAs has been reported. Typically, cross-reactivity to some extent is observed within a subtype (e.g., within N1) (<xref rid="B18" ref-type="bibr">18</xref>
, <xref rid="B22" ref-type="bibr">22</xref>
, <xref rid="B23" ref-type="bibr">23</xref>
, <xref rid="B31" ref-type="bibr">31</xref>
, <xref rid="B59" ref-type="bibr">59</xref>
) but not across subtypes (e.g., N1 to N2) (<xref rid="B23" ref-type="bibr">23</xref>
). The exception is an epitope reported to induce reactivity across all NA subtypes, including cross-reactivity between influenza A and B NAs, albeit with low inhibiting and protective effects (<xref rid="B60" ref-type="bibr">60</xref>
, <xref rid="B61" ref-type="bibr">61</xref>
). Thus, data about the breadth of the NA response is limited and has mostly been generated from animal models. Human data, ideally based on monoclonal antibodies, needs to be generated in order to conclusively understand NA’s potential as a broadly protective antigen.</p>
</sec>
<sec id="s2.8"><title>Antigenic drift.</title>
<p>Antigenic drift occurs in NA but has largely been ignored. Preliminary studies describe the drift rates as discordant and somewhat lower than the drift rates of HA (<xref rid="B34" ref-type="bibr">34</xref>
, <xref rid="B62" ref-type="bibr">62</xref>
, <xref rid="B63" ref-type="bibr">63</xref>
). While some of these data have been generated using H6N<italic>X</italic>
reagents (the <italic>X</italic>
stands for the NA subtype) for NI assays, older data are based on wild-type virus reagents and are less reliable. To better understand the antigenic drift of N1, N2, and influenza B NAs, it is necessary to extend antigenic cartography (for which NA-specific antisera against matched and mismatched strains are needed), characterize epitopes using human sera and MAbs, and include NA sequencing into routine surveillance.</p>
</sec>
<sec id="s2.9"><title>Is N2 more immunogenic than N1?</title>
<p>Several studies have shown more robust immunity to N2 than to N1 in humans (<xref rid="B23" ref-type="bibr">23</xref>
, <xref rid="B53" ref-type="bibr">53</xref>
, <xref rid="B64" ref-type="bibr">64</xref>
, <xref rid="B65" ref-type="bibr">65</xref>
). It is unclear whether this is an artifact of the assays used or whether this is caused by an inherent difference in terms of protein stability or immunogenicity.</p>
</sec>
<sec id="s2.10"><title>Mucosal immunity.</title>
<p>Our knowledge about serum antibody responses to NA is limited, and even less is known about mucosal antibody responses to NA. It is unclear to what level mucosal antibodies against N1, N2, and influenza B NAs are induced by infection, inactivated vaccines, and LAIV and how long-lived these responses are. Given the role of NA in trafficking virus to and from the site of infection in the respiratory tract, these are very relevant for protection in humans, and therefore NA-specific immunity at the mucosal surface is a critical gap in our knowledge.</p>
</sec>
<sec id="s2.11"><title>Mechanisms of action of anti-NA antibodies.</title>
<p>Many antibodies that target NA can inhibit its enzymatic function. This might inhibit viral egress from infected cells. The role of anti-NA immunity in inhibiting the release of incoming virions trapped by mucins on mucosal surfaces is less clear. Also, the role of anti-NA immunity in virus aggregation is unclear. The last two points are important, since NA-based immunity, if robust enough, might have a significant impact on the transmission of the virus, which might increase the effectiveness of the influenza virus vaccine even in areas with low vaccine coverage. Finally, it has been reported that some of the currently circulating H3N2 viruses use their NA instead of their HA for attachment to cells (<xref rid="B66" ref-type="bibr">66</xref>
<xref ref-type="bibr" rid="B67">–</xref>
<xref rid="B68" ref-type="bibr">68</xref>
). In this case, anti-NA antibodies might also have HI activity.</p>
</sec>
<sec id="s2.12"><title>Contribution to receptor specificity.</title>
<p>NA binds to sialic acid in order to cleave it. This modulates the receptor binding specificity of viral particles, but our knowledge about this activity and about the receptor specificities of different NAs is limited. It is also unclear how this might be modulated by anti-NA immunity.</p>
</sec>
<sec id="s2.13"><title>Effector functions of anti-NA antibodies.</title>
<p>Antibody effector functions, like antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP), have been found to be important mechanisms of action of broadly protective anti-HA antibodies (<xref rid="B69" ref-type="bibr">69</xref>
<xref ref-type="bibr" rid="B70">–</xref>
<xref rid="B72" ref-type="bibr">72</xref>
). Very little is known about the effector function of anti-NA antibodies, and this needs to be explored. Interestingly, binding of HA to sialic acid on effector cells enhances the ADCC activity of anti-HA MAbs (<xref rid="B73" ref-type="bibr">73</xref>
, <xref rid="B74" ref-type="bibr">74</xref>
). It can be hypothesized that the enzymatic activity of NA, which cleaves sialic acid, counteracts this mechanism. Inhibition of the NA enzymatic activity through antibodies might therefore mediate effector functions on its own and enhance effector functions of anti-HA antibodies by blocking the NA activity (<xref rid="B75" ref-type="bibr">75</xref>
<xref ref-type="bibr" rid="B76">–</xref>
<xref rid="B77" ref-type="bibr">77</xref>
). Studies to address these questions are urgently needed.</p>
</sec>
<sec id="s2.14"><title>T-cell epitopes.</title>
<p>Early studies demonstrated that NA contains a number of CD4<sup>+</sup>
and CD8<sup>+</sup>
T-cell epitopes in mice (<xref rid="B78" ref-type="bibr">78</xref>
, <xref rid="B79" ref-type="bibr">79</xref>
). NA is also the target of human CD4<sup>+</sup>
and CD8<sup>+</sup>
T cells, with epitopes listed in the Immune Epitope Database (IEDB; <ext-link ext-link-type="uri" xlink:href="http://www.iedb.org/">http://www.iedb.org/</ext-link>
). We therefore expect a robust T-cell-dependent antibody response when NA is used as a stand-alone vaccine, with potential to induce cytotoxic CD8<sup>+</sup>
T cells when delivered with appropriate adjuvants, as live attenuated vaccine or by a viral vector. Studies to evaluate NA-specific T-cell responses are needed to design optimal NA-based vaccines.</p>
</sec>
<sec id="s2.15"><title>NA glycosylation.</title>
<p>NA is a glycoprotein with several N-linked glycosylation sites. Some of them are conserved, and others change over time. The role of glycosylation in enzymatic activity, immune evasion, and antigenic drift deserves further study.</p>
</sec>
<sec id="s2.16"><title>Modulation of immune mediators.</title>
<p>We know that NA can activate transforming growth factor β (TGF-β) during infections (<xref rid="B80" ref-type="bibr">80</xref>
, <xref rid="B81" ref-type="bibr">81</xref>
). The underlying mechanism and the consequences for the host are not well understood. At low virus doses, NA enhances the ability of dendritic cells to initiate a T-cell response, but at high virus doses, NA contributes to the induction of Th2-type cytokines that may be associated with adverse events (<xref rid="B82" ref-type="bibr">82</xref>
<xref ref-type="bibr" rid="B83">–</xref>
<xref rid="B85" ref-type="bibr">85</xref>
). Whether an NA-based vaccine will activate TGF-β and influence the quality of the immune response needs to be examined. In addition, studies counteracting these mechanisms during infection with NA-targeting antibodies should be conducted to determine the overall benefit of NA immunity to the host. The functional consequences of NA activity on initiation of the immune response and of NA-specific antibodies on effector functions during virus challenge certainly need to be evaluated.</p>
</sec>
</sec>
<sec id="s3"><title>WHICH ASSAYS EXIST, AND WHAT ARE THEIR LIMITATIONS?</title>
<p>Several assays to analyze the NA contents of vaccines, the NA integrity of vaccine preparations, and anti-NA antibody responses have been designed and are currently in use. For immune assays, it should be noted (as discussed above) that we lack a good understanding of which readouts correlate with protection.</p>
<sec id="s3.1"><title>Assays to determine the NA contents of vaccines.</title>
<p>The simplest, although only semiquantitative, way of measuring the NA contents of influenza virus vaccines is by reducing SDS-PAGE followed by Western blotting using a protein standard and strain/subtype-specific polyclonal or monoclonal antibody (<xref rid="B23" ref-type="bibr">23</xref>
). While this method does not allow for the assessment of the structural integrity of NA (besides its very obvious proteolytic degradation), it can be an easy way to get a good estimate of how much NA is present in the vaccine, and it can be used to compare different vaccine preparations, formulations, and lots. A better method is the use of quantitative enzyme-linked immunosorbent assays (ELISAs) to directly measure NA concentrations. Depending on the capture and/or detection antibody chosen, these assays can be used to actually measure correctly folded NA (<xref rid="B86" ref-type="bibr">86</xref>
). A chip-based VaxArray (<xref rid="B87" ref-type="bibr">87</xref>
) assay using the same principle is under development (personal communication, Kathy Rowlen, InDevR). In addition, high-performance liquid chromatography (HPLC)- and mass spectrometry-based methods have been developed, but they are more burdensome and do not necessarily indicate protein integrity (<xref rid="B52" ref-type="bibr">52</xref>
, <xref rid="B88" ref-type="bibr">88</xref>
). Finally, NA activity assays might be of value as well in analyzing the quality of NAs present in vaccines, since only tetrameric NA has strong sialidase activity (<xref rid="B53" ref-type="bibr">53</xref>
). However, these assays are useful only with monovalent vaccines, because they cannot specifically measure the activity of each strain/subtype in a multivalent vaccine.</p>
</sec>
<sec id="s3.2"><title>Assays to characterize the anti-NA immune response.</title>
<p>ELISAs are a relatively easy way to measure immune responses to NA. They can be performed with serum or other bodily fluids (e.g., nasal washes); with different secondary antibodies, the immune response can be dissected into different IgG subtypes and IgA, sIgA, and IgM responses. The assay can be performed in a quantitative way by measuring endpoint titers or by performing an area under the curve analysis. To evaluate NA responses, the use of recombinant, tetrameric, glycosylated, and enzymatically active NA as the substrate is likely the best choice. While ELISAs yield binding data, they do not inform about the functionality of the measured antibody response. However, the ELISA titers usually correlate well with NI titers measured in functional assays (<xref rid="B64" ref-type="bibr">64</xref>
). Several assays to measure the enzymatic activity of NA exist. Many of these assays are based on cleavage of a small molecule that subsequently leads to the development of a signal (<xref rid="B89" ref-type="bibr">89</xref>
) (<ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/44518/1/9789241548090_eng.pdf">http://apps.who.int/iris/bitstream/10665/44518/1/9789241548090_eng.pdf</ext-link>
). However, unlike terminal sialic acid, which is attached to glycans on bulky proteins, these small molecules have easy access to the active site of the NA. To show NI activity in a small-molecule-based assay, an antibody needs to bind very close to the active site and/or inhibit the active site allosterically. However, anti-NA MAbs can also block NA activity by steric hindrance of the natural substrate-NA interaction, since the substrate, terminal sialic acid, is usually attached to a large bulky glycoprotein or glycolipid. Therefore, the enzyme-linked lectin assay (ELLA) that uses fetuin, a highly sialylated glycoprotein, as the substrate was developed to measure NI antibody titers in a more realistic way (<xref rid="B20" ref-type="bibr">20</xref>
, <xref rid="B90" ref-type="bibr">90</xref>
). This assay is relatively simple and can be performed in almost any laboratory that has access to a plate reader. The key reagent for the ELLA is the target NA to which NI activities of sera or MAbs should be measured. The NA can be used in the form of a virus or as purified NA. If wild-type virus is used, the fact that antibodies that bind to the HA head domain exhibit strong NI activity due to steric hindrance needs to be taken into account as well (<xref rid="B19" ref-type="bibr">19</xref>
, <xref rid="B91" ref-type="bibr">91</xref>
). While it is sometimes useful to know the potential of serum to inhibit NA activity regardless of whether it is mediated by binding to NA or other targets (<xref rid="B92" ref-type="bibr">92</xref>
), it is usually of interest to measure NA-specific inhibition. To accomplish this, H6N<italic>X</italic>
and/or H7N<italic>X</italic>
reassortant viruses are commonly used to reduce the impact of anti-HA antibodies on the assays (<xref rid="B20" ref-type="bibr">20</xref>
, <xref rid="B63" ref-type="bibr">63</xref>
, <xref rid="B91" ref-type="bibr">91</xref>
). However, it needs to be noted that antistalk antibodies that broadly bind to HAs (including H6) might interfere with the assay in some cases too (<xref rid="B64" ref-type="bibr">64</xref>
). Virus-like particles (VLPs) with mismatched HAs might be used for NI assays as well (<xref rid="B93" ref-type="bibr">93</xref>
). Another possibility is to perform the NI assay with recombinant NA, which eliminates issues with non-NA-specific inhibition (<xref rid="B94" ref-type="bibr">94</xref>
, <xref rid="B95" ref-type="bibr">95</xref>
). However, soluble NA might have enzyme kinetics different from that of membrane-bound NAs, and it seems that HA on virions also plays an important part in bringing NA and the substrate in the assay into close proximity (<xref rid="B96" ref-type="bibr">96</xref>
). Pseudotyped viruses and detergent-disrupted viruses have also been used as antigens to measure NA inhibition antibody titers (<xref rid="B50" ref-type="bibr">50</xref>
, <xref rid="B97" ref-type="bibr">97</xref>
). The ELLA with H6N<italic>X</italic>
viruses (or viruses with other exotic HAs, e.g., H7N<italic>X</italic>
) is, however, recommended as the gold standard assay for measuring NI activity. Finally, NA-based assays to measure effector functions of antibodies might be useful in the future (<xref rid="B16" ref-type="bibr">16</xref>
, <xref rid="B75" ref-type="bibr">75</xref>
). These assays could be designed by following protocols of current assays for measuring effector functions (e.g., the ADCC and ADCP reporter assays that are in wide use) with target cells that have been transfected to express NA only (instead of infected cells).</p>
</sec>
</sec>
<sec id="s4"><title>WHAT KIND OF REAGENTS HAVE BEEN CREATED, AND FROM WHERE CAN THEY BE SOURCED?</title>
<p>Reagents for the assays listed above are still relatively scarce compared to reagents for HA-based assays. Here, we list the available reagents as well as their advantages and disadvantages. Main characteristics and sources can be found in <xref ref-type="table" rid="tab1">Table 1</xref>
. As mentioned above, it has become good practice to use H6N<italic>X</italic>
viruses (or other viruses that express mismatched HA subtypes) for NI assays to reduce the influence of non-NA antibodies on the assay. These viruses are typically generated by reverse genetics using an avian H6 HA in combination with the target NA. Relatively large panels of H6N1 and H6N2 viruses for ELLAs have been developed and can be requested from members of this group (reagents that target other subtypes of NA, like H6N9, exist as well). While analysis of influenza B viruses was restricted to wild-type viruses until recently, H6NB viruses have now also been rescued (<xref rid="B64" ref-type="bibr">64</xref>
). While an H6 HA is commonly used for these reassortants, other exotic HA subtypes can be used as well (e.g., H7N<italic>X</italic>
) but may result in the need to treat the serum samples to remove HA-specific inhibitors (<xref rid="B63" ref-type="bibr">63</xref>
). However, two caveats with these viruses need to be kept in mind. First, stalk-reactive antibodies might interfere with the assay and induce a low level of NI background (<xref rid="B19" ref-type="bibr">19</xref>
, <xref rid="B64" ref-type="bibr">64</xref>
). Second, when wild-type viruses and H6N<italic>X</italic>
viruses with the same NAs were tested <italic>in vitro</italic>
with MAbs, the NI activities differed slightly between the viruses (<xref rid="B64" ref-type="bibr">64</xref>
). This might be caused by different HA/NA ratios between wild-type and H6N<italic>X</italic>
viruses or by differences in the affinities of the HAs toward the substrate (see above), and it is unclear whether this also occurs with polyclonal sera. Nevertheless, H6N<italic>X</italic>
reassortant viruses are currently seen as the best reagent to measure NI activity (except when testing sera from animals that have been vaccinated with NA-only vaccines). Recombinant NA can be a very useful reagent for ELISAs and other assays, as well as for vaccination studies, to create NA-specific antisera. Recombinant NA should ideally be expressed as a tetramer with fully functional enzymatic activity to preserve as much of the antigenic structure as possible (<xref rid="B23" ref-type="bibr">23</xref>
, <xref rid="B94" ref-type="bibr">94</xref>
, <xref rid="B98" ref-type="bibr">98</xref>
, <xref rid="B99" ref-type="bibr">99</xref>
). Typically, only the head domain of the NA is expressed as a fusion protein with a tetramerization domain in insect cells or mammalian cells (<xref rid="B100" ref-type="bibr">100</xref>
). A production process for full-length NA from insect cells has also been developed but involves considerable downstream processing (<xref rid="B57" ref-type="bibr">57</xref>
). NA expressed in bacterial systems is unlikely to be correctly folded and representative of virus-derived NA. Of note, even when expressed under the best conditions, some NAs are unstable in the form of their recombinant proteins. A selection of recombinant NA proteins is available commercially or from the International Reagent Resource (IRR) or BEI Resources. Larger panels might be requested from this group, and considerable efforts are made to make more NAs available, but expression and purification of NA are costly and need support. In addition, a larger number of MAbs and NA-specific polyclonal sera are needed as reagents for use in antigenic cartography, potency ELISAs, Western blot assays, competition assays, and positive controls in NI and serum ELISAs.</p>
<table-wrap id="tab1" orientation="portrait" position="float"><label>TABLE 1 </label>
<caption><p>Useful reagents for evaluation of NA contents of vaccines and NA-directed immunity</p>
</caption>
<table frame="hsides" rules="groups"><colgroup span="1"><col span="1"></col>
<col span="1"></col>
<col span="1"></col>
<col span="1"></col>
<col span="1"></col>
</colgroup>
<thead><tr><th rowspan="1" colspan="1">Reagent(s)</th>
<th rowspan="1" colspan="1">Assay(s)<xref ref-type="table-fn" rid="ngtab1.1"><sup>a</sup>
</xref>
</th>
<th rowspan="1" colspan="1">Comment</th>
<th rowspan="1" colspan="1">Availability<xref ref-type="table-fn" rid="ngtab1.2"><sup>b</sup>
</xref>
</th>
<th rowspan="1" colspan="1">Reference</th>
</tr>
</thead>
<tbody><tr><td rowspan="1" colspan="1">H6N<italic>X</italic>
viruses</td>
<td rowspan="1" colspan="1">NI</td>
<td rowspan="1" colspan="1">Viruses containing avian<break></break>
components (e.g., H6)<break></break>
might need specific<break></break>
permits for shipping<break></break>
and use</td>
<td rowspan="1" colspan="1">Available upon request from Hongquan Wan (FDA),<break></break>
Richard Webby (St. Jude Children’s Research<break></break>
Hospital), and Florian Krammer (Icahn School of<break></break>
Medicine at Mount Sinai)</td>
<td rowspan="1" colspan="1"><xref rid="B20" ref-type="bibr">20</xref>
, <xref rid="B64" ref-type="bibr">64</xref>
, <xref rid="B90" ref-type="bibr">90</xref>
,<break></break>
<xref rid="B91" ref-type="bibr">91</xref>
</td>
</tr>
<tr><td rowspan="1" colspan="1">Fetuin</td>
<td rowspan="1" colspan="1">NI</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">Widely commercially available</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr><td rowspan="1" colspan="1">Horseradish<break></break>
peroxidase-<break></break>
labeled<break></break>
peanut<break></break>
agglutinin</td>
<td rowspan="1" colspan="1">NI</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">Widely commercially available</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr><td rowspan="1" colspan="1">Recombinant<break></break>
NA</td>
<td rowspan="1" colspan="1">ELISA, NI, and WB<break></break>
(as the standard)<break></break>
for NA-specific<break></break>
serum generation<break></break>
and NA binding<break></break>
studies</td>
<td rowspan="1" colspan="1">Only functional, glycosylated,<break></break>
tetrameric NA expressed<break></break>
in mammalian cells or<break></break>
insect cells should be used</td>
<td rowspan="1" colspan="1">Available from BEI Resources (<ext-link ext-link-type="uri" xlink:href="https://www.beiresources.org/">https://www.beiresources.org/</ext-link>
),<break></break>
International Reagent Resource<break></break>
(<ext-link ext-link-type="uri" xlink:href="https://www.internationalreagentresource.org/">https://www.internationalreagentresource.org/</ext-link>
), and<break></break>
commercial sources, and limited amounts are available<break></break>
upon request from Florian Krammer (Icahn School<break></break>
of Medicine at Mount Sinai); these reagents are difficult<break></break>
and costly to produce and are<break></break>
therefore available only in small quantities</td>
<td rowspan="1" colspan="1"><xref rid="B23" ref-type="bibr">23</xref>
, <xref rid="B94" ref-type="bibr">94</xref>
,<break></break>
<xref rid="B98" ref-type="bibr">98–100</xref>
</td>
</tr>
<tr><td rowspan="1" colspan="1">Anti-NA MAbs</td>
<td rowspan="1" colspan="1">Capture ELISA for NA<break></break>
quantification,<break></break>
competition assays,<break></break>
and assay positive<break></break>
controls</td>
<td rowspan="1" colspan="1">Useful for different purposes,<break></break>
depending on the nature<break></break>
of the epitope recognized<break></break>
(linear versus conformation<break></break>
dependent)</td>
<td rowspan="1" colspan="1">Some MAbs are available upon request from Hongquan<break></break>
Wan (FDA), Florian Krammer (Icahn School of Medicine<break></break>
at Mount Sinai), and others; in general,<break></break>
there is a paucity of anti-NA MAbs, and additional ones<break></break>
against different strains and subtypes are needed</td>
<td rowspan="1" colspan="1"><xref rid="B16" ref-type="bibr">16</xref>
, <xref rid="B18" ref-type="bibr">18</xref>
,<break></break>
<xref rid="B23" ref-type="bibr">23</xref>
, <xref rid="B35" ref-type="bibr">35</xref>
,<break></break>
<xref rid="B86" ref-type="bibr">86</xref>
</td>
</tr>
<tr><td rowspan="1" colspan="1">Anti-NA<break></break>
polyclonal<break></break>
sera</td>
<td rowspan="1" colspan="1">Positive controls, WB,<break></break>
and antigenic<break></break>
cartography</td>
<td rowspan="1" colspan="1">NA specific versus virus<break></break>
specific</td>
<td rowspan="1" colspan="1">Not widely available; there is a need to generate these<break></break>
reagents; very limited amounts for some strains are<break></break>
available from Ron Fouchier (Erasmus Medical Center)</td>
<td rowspan="1" colspan="1"><xref rid="B63" ref-type="bibr">63</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot><fn fn-type="other" id="ngtab1.1"><label>a</label>
<p>WB, Western blotting.</p>
</fn>
<fn fn-type="other" id="ngtab1.2"><label>b</label>
<p>These reagents might be requested, but availability is not guaranteed and might depend on legal restrictions, available resources, and funding to produce batches and other factors.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec sec-type="conclusions" id="s5"><title>CONCLUSIONS</title>
<p>NA is a fascinating protein that plays multiple essential roles in the influenza virus life cycle. In addition, there is evidence that NA is an important and protective antigen. In order to confirm that role and to harness NA-based immunity optimally to enhance the breadth of influenza virus vaccines and increase vaccine efficacy, studies that answer the questions stated above are urgently needed. In addition, clinical trials and observational studies that evaluate NA-based and/or NA-enhanced vaccines in humans are needed. These are major efforts, but we feel that they are necessary to reveal the full potential of influenza virus vaccines, both for currently licensed seasonal vaccines and for future broadly protective or universal influenza virus vaccines (<xref rid="B101" ref-type="bibr">101</xref>
). To facilitate these efforts, the NAction! focus group was formed within the CEIRS network by experts in NA-based immunity and includes major stakeholders outside the CEIRS network. We invite other researchers with a strong interest in NA-based immunity to contribute to these efforts and/or join the group by contacting the CEIRS program officer, Marciela DeGrace (<email>marciela.degrace@nih.gov</email>
), at NIAID.</p>
</sec>
</body>
<back><fn-group><fn fn-type="other"><p><bold>Citation</bold>
Krammer F, Fouchier RAM, Eichelberger MC, Webby RJ, Shaw-Saliba K, Wan H, Wilson PC, Compans RW, Skountzou I, Monto AS. 2018. NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines? mBio 9:e02332-17. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mBio.02332-17">https://doi.org/10.1128/mBio.02332-17</ext-link>
.</p>
</fn>
</fn-group>
<ack><title>ACKNOWLEDGMENTS</title>
<p>We thank Ericka Kirkpatrick, Icahn School of Medicine at Mount Sinai, for help with figures. We further thank Marciela DeGrace and Diane Post at the NIAID for facilitating the formation of this group and for fruitful discussion and Chris Roberts for championing support for NA vaccine research at the NIAID. Finally, we also thank Bert Johansson for digging out the 2000 abstract about the clinical trial with an NA-supplemented trivalent influenza virus vaccine. NA-focused work in our laboratories is supported by the following: NIAID CEIRS contracts HHSN272201400008C (F.K., R.A.M.F.), HHSN272201400007C (K.S.-S.), HHSN272201400006C (R.J.W.), HHSN272201400005C (P.C.W.), and HHSN272201400004C (I.S., R.W.C.); NIAID grants R01 AI117287 (focused on influenza B NA, F.K.), U19 AI109946 (P.C.W.), and R56 AI097150 (A.S.M.); Biomedical Advanced Research and Development Authority (BARDA) contract HHSO100201500033C (R.A.M.F.); and CBER (FDA) intramural funds (H.W., M.C.E.).</p>
</ack>
<ref-list><title>REFERENCES</title>
<ref id="B1"><label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Russell</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology</article-title>
. <source>Curr Top Microbiol Immunol</source>
<volume>385</volume>
:<fpage>93</fpage>
–<lpage>116</lpage>
. doi:<pub-id pub-id-type="doi">10.1007/82_2014_393</pub-id>
.<pub-id pub-id-type="pmid">25007844</pub-id>
</mixed-citation>
</ref>
<ref id="B2"><label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Graaf</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Fouchier</surname>
<given-names>RA</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Role of receptor binding specificity in influenza A virus transmission and pathogenesis</article-title>
. <source>EMBO J</source>
<volume>33</volume>
:<fpage>823</fpage>
–<lpage>841</lpage>
. doi:<pub-id pub-id-type="doi">10.1002/embj.201387442</pub-id>
.<pub-id pub-id-type="pmid">24668228</pub-id>
</mixed-citation>
</ref>
<ref id="B3"><label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Advances in the development of influenza virus vaccines</article-title>
. <source>Nat Rev Drug Discov</source>
<volume>14</volume>
:<fpage>167</fpage>
–<lpage>182</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/nrd4529</pub-id>
.<pub-id pub-id-type="pmid">25722244</pub-id>
</mixed-citation>
</ref>
<ref id="B4"><label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berlanda Scorza</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Tsvetnitsky</surname>
<given-names>V</given-names>
</name>
, <name name-style="western"><surname>Donnelly</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Universal influenza vaccines: shifting to better vaccines</article-title>
. <source>Vaccine</source>
<volume>34</volume>
:<fpage>2926</fpage>
–<lpage>2933</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.03.085</pub-id>
.<pub-id pub-id-type="pmid">27038130</pub-id>
</mixed-citation>
</ref>
<ref id="B5"><label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohlbold</surname>
<given-names>TJ</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen</article-title>
. <source>Viruses</source>
<volume>6</volume>
:<fpage>2465</fpage>
–<lpage>2494</lpage>
. doi:<pub-id pub-id-type="doi">10.3390/v6062465</pub-id>
.<pub-id pub-id-type="pmid">24960271</pub-id>
</mixed-citation>
</ref>
<ref id="B6"><label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
, <name name-style="western"><surname>Wan</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Influenza neuraminidase as a vaccine antigen</article-title>
. <source>Curr Top Microbiol Immunol</source>
<volume>386</volume>
:<fpage>275</fpage>
–<lpage>299</lpage>
. doi:<pub-id pub-id-type="doi">10.1007/82_2014_398</pub-id>
.<pub-id pub-id-type="pmid">25033754</pub-id>
</mixed-citation>
</ref>
<ref id="B7"><label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Zhang</surname>
<given-names>XQ</given-names>
</name>
, <name name-style="western"><surname>Senaati</surname>
<given-names>HP</given-names>
</name>
, <name name-style="western"><surname>Chen</surname>
<given-names>HW</given-names>
</name>
, <name name-style="western"><surname>Varki</surname>
<given-names>NM</given-names>
</name>
, <name name-style="western"><surname>Schooley</surname>
<given-names>RT</given-names>
</name>
, <name name-style="western"><surname>Gagneux</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase</article-title>
. <source>Virol J</source>
<volume>10</volume>
:<fpage>321</fpage>
. doi:<pub-id pub-id-type="doi">10.1186/1743-422X-10-321</pub-id>
.<pub-id pub-id-type="pmid">24261589</pub-id>
</mixed-citation>
</ref>
<ref id="B8"><label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname>
<given-names>X</given-names>
</name>
, <name name-style="western"><surname>Steukers</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Forier</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Xiong</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Braeckmans</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Van Reeth</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Nauwynck</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus</article-title>
. <source>PLoS One</source>
<volume>9</volume>
:<elocation-id>e110026</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0110026</pub-id>
.<pub-id pub-id-type="pmid">25333824</pub-id>
</mixed-citation>
</ref>
<ref id="B9"><label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matrosovich</surname>
<given-names>MN</given-names>
</name>
, <name name-style="western"><surname>Matrosovich</surname>
<given-names>TY</given-names>
</name>
, <name name-style="western"><surname>Gray</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Roberts</surname>
<given-names>NA</given-names>
</name>
, <name name-style="western"><surname>Klenk</surname>
<given-names>HD</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium</article-title>
. <source>J Virol</source>
<volume>78</volume>
:<fpage>12665</fpage>
–<lpage>12667</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.78.22.12665-12667.2004</pub-id>
.<pub-id pub-id-type="pmid">15507653</pub-id>
</mixed-citation>
</ref>
<ref id="B10"><label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Rubin</surname>
<given-names>BK</given-names>
</name>
, <name name-style="western"><surname>Voynow</surname>
<given-names>JA</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Mucins, mucus, and goblet cells</article-title>
. <source>Chest</source>
. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2017.11.008</pub-id>
.</mixed-citation>
</ref>
<ref id="B11"><label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matrosovich</surname>
<given-names>MN</given-names>
</name>
, <name name-style="western"><surname>Matrosovich</surname>
<given-names>TY</given-names>
</name>
, <name name-style="western"><surname>Gray</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Roberts</surname>
<given-names>NA</given-names>
</name>
, <name name-style="western"><surname>Klenk</surname>
<given-names>HD</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Human and avian influenza viruses target different cell types in cultures of human airway epithelium</article-title>
. <source>Proc Natl Acad Sci U S A</source>
<volume>101</volume>
:<fpage>4620</fpage>
–<lpage>4624</lpage>
. doi:<pub-id pub-id-type="doi">10.1073/pnas.0308001101</pub-id>
.<pub-id pub-id-type="pmid">15070767</pub-id>
</mixed-citation>
</ref>
<ref id="B12"><label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilbourne</surname>
<given-names>ED</given-names>
</name>
, <name name-style="western"><surname>Laver</surname>
<given-names>WG</given-names>
</name>
, <name name-style="western"><surname>Schulman</surname>
<given-names>JL</given-names>
</name>
, <name name-style="western"><surname>Webster</surname>
<given-names>RG</given-names>
</name>
</person-group>
<year>1968</year>
<article-title>Antiviral activity of antiserum specific for an influenza virus neuraminidase</article-title>
. <source>J Virol</source>
<volume>2</volume>
:<fpage>281</fpage>
–<lpage>288</lpage>
.<pub-id pub-id-type="pmid">4911843</pub-id>
</mixed-citation>
</ref>
<ref id="B13"><label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname>
<given-names>B</given-names>
</name>
, <name name-style="western"><surname>Wurtzer</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Rameix-Welti</surname>
<given-names>MA</given-names>
</name>
, <name name-style="western"><surname>Dwyer</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>van der Werf</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Naffakh</surname>
<given-names>N</given-names>
</name>
, <name name-style="western"><surname>Clavel</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Labrosse</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA)</article-title>
. <source>PLoS One</source>
<volume>4</volume>
:<elocation-id>e8495</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0008495</pub-id>
.<pub-id pub-id-type="pmid">20041119</pub-id>
</mixed-citation>
</ref>
<ref id="B14"><label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakai</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Nishimura</surname>
<given-names>SI</given-names>
</name>
, <name name-style="western"><surname>Naito</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Saito</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Influenza A virus hemagglutinin and neuraminidase act as novel motile machinery</article-title>
. <source>Sci Rep</source>
<volume>7</volume>
:<fpage>45043</fpage>
. doi:<pub-id pub-id-type="doi">10.1038/srep45043</pub-id>
.<pub-id pub-id-type="pmid">28344335</pub-id>
</mixed-citation>
</ref>
<ref id="B15"><label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen-Van-Tam</surname>
<given-names>JS</given-names>
</name>
, <name name-style="western"><surname>Venkatesan</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Muthuri</surname>
<given-names>SG</given-names>
</name>
, <name name-style="western"><surname>Myles</surname>
<given-names>PR</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Neuraminidase inhibitors: who, when, where?</article-title>
<source>Clin Microbiol Infect</source>
<volume>21</volume>
:<fpage>222</fpage>
–<lpage>225</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.cmi.2014.11.020</pub-id>
.<pub-id pub-id-type="pmid">25703253</pub-id>
</mixed-citation>
</ref>
<ref id="B16"><label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohlbold</surname>
<given-names>TJ</given-names>
</name>
, <name name-style="western"><surname>Podolsky</surname>
<given-names>KA</given-names>
</name>
, <name name-style="western"><surname>Chromikova</surname>
<given-names>V</given-names>
</name>
, <name name-style="western"><surname>Kirkpatrick</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Falconieri</surname>
<given-names>V</given-names>
</name>
, <name name-style="western"><surname>Meade</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Amanat</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Tan</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>tenOever</surname>
<given-names>BR</given-names>
</name>
, <name name-style="western"><surname>Tan</surname>
<given-names>GS</given-names>
</name>
, <name name-style="western"><surname>Subramaniam</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes</article-title>
. <source>Nat Microbiol</source>
<volume>2</volume>
:<fpage>1415</fpage>
–<lpage>1424</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/s41564-017-0011-8</pub-id>
.<pub-id pub-id-type="pmid">28827718</pub-id>
</mixed-citation>
</ref>
<ref id="B17"><label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Fantoni</surname>
<given-names>G</given-names>
</name>
, <name name-style="western"><surname>Couzens</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Plant</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Ye</surname>
<given-names>Z</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
, <name name-style="western"><surname>Wan</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Comparative efficacy of monoclonal antibodies that bind to different epitopes of the 2009 pandemic H1N1 influenza virus neuraminidase</article-title>
. <source>J Virol</source>
<volume>90</volume>
:<fpage>117</fpage>
–<lpage>128</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.01756-15</pub-id>
.<pub-id pub-id-type="pmid">26468531</pub-id>
</mixed-citation>
</ref>
<ref id="B18"><label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Xu</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Chen</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Couzens</surname>
<given-names>LK</given-names>
</name>
, <name name-style="western"><surname>Rivers</surname>
<given-names>KH</given-names>
</name>
, <name name-style="western"><surname>Easterbrook</surname>
<given-names>JD</given-names>
</name>
, <name name-style="western"><surname>Yang</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Zhong</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Rajabi</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Ye</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Sultana</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Wan</surname>
<given-names>XF</given-names>
</name>
, <name name-style="western"><surname>Liu</surname>
<given-names>X</given-names>
</name>
, <name name-style="western"><surname>Perez</surname>
<given-names>DR</given-names>
</name>
, <name name-style="western"><surname>Taubenberger</surname>
<given-names>JK</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses</article-title>
. <source>J Virol</source>
<volume>87</volume>
:<fpage>9290</fpage>
–<lpage>9300</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.01203-13</pub-id>
.<pub-id pub-id-type="pmid">23785204</pub-id>
</mixed-citation>
</ref>
<ref id="B19"><label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohlbold</surname>
<given-names>TJ</given-names>
</name>
, <name name-style="western"><surname>Chromikova</surname>
<given-names>V</given-names>
</name>
, <name name-style="western"><surname>Tan</surname>
<given-names>GS</given-names>
</name>
, <name name-style="western"><surname>Meade</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Amanat</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Comella</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Hirsh</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice</article-title>
. <source>J Virol</source>
<volume>90</volume>
:<fpage>851</fpage>
–<lpage>861</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.02275-15</pub-id>
H10N8.<pub-id pub-id-type="pmid">26512088</pub-id>
</mixed-citation>
</ref>
<ref id="B20"><label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Couzens</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Westgeest</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Sandbulte</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Lugovtsev</surname>
<given-names>V</given-names>
</name>
, <name name-style="western"><surname>Fouchier</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera</article-title>
. <source>J Virol Methods</source>
<volume>210</volume>
:<fpage>7</fpage>
–<lpage>14</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.jviromet.2014.09.003</pub-id>
.<pub-id pub-id-type="pmid">25233882</pub-id>
</mixed-citation>
</ref>
<ref id="B21"><label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulman</surname>
<given-names>JL</given-names>
</name>
, <name name-style="western"><surname>Khakpour</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Kilbourne</surname>
<given-names>ED</given-names>
</name>
</person-group>
<year>1968</year>
<article-title>Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice</article-title>
. <source>J Virol</source>
<volume>2</volume>
:<fpage>778</fpage>
–<lpage>786</lpage>
.<pub-id pub-id-type="pmid">5701819</pub-id>
</mixed-citation>
</ref>
<ref id="B22"><label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Easterbrook</surname>
<given-names>JD</given-names>
</name>
, <name name-style="western"><surname>Schwartzman</surname>
<given-names>LM</given-names>
</name>
, <name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Kash</surname>
<given-names>JC</given-names>
</name>
, <name name-style="western"><surname>Morens</surname>
<given-names>DM</given-names>
</name>
, <name name-style="western"><surname>Couzens</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Wan</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
, <name name-style="western"><surname>Taubenberger</surname>
<given-names>JK</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice</article-title>
. <source>Virology</source>
<volume>432</volume>
:<fpage>39</fpage>
–<lpage>44</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.virol.2012.06.003</pub-id>
.<pub-id pub-id-type="pmid">22727831</pub-id>
</mixed-citation>
</ref>
<ref id="B23"><label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohlbold</surname>
<given-names>TJ</given-names>
</name>
, <name name-style="western"><surname>Nachbagauer</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Xu</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Tan</surname>
<given-names>GS</given-names>
</name>
, <name name-style="western"><surname>Hirsh</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Brokstad</surname>
<given-names>KA</given-names>
</name>
, <name name-style="western"><surname>Cox</surname>
<given-names>RJ</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice</article-title>
. <source>mBio</source>
<volume>6</volume>
. doi:<pub-id pub-id-type="doi">10.1128/mBio.02556-14</pub-id>
.</mixed-citation>
</ref>
<ref id="B24"><label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname>
<given-names>WC</given-names>
</name>
, <name name-style="western"><surname>Lin</surname>
<given-names>CY</given-names>
</name>
, <name name-style="western"><surname>Tsou</surname>
<given-names>YT</given-names>
</name>
, <name name-style="western"><surname>Jan</surname>
<given-names>JT</given-names>
</name>
, <name name-style="western"><surname>Wu</surname>
<given-names>SC</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Cross-reactive neuraminidase-inhibiting antibodies elicited by immunization with recombinant neuraminidase proteins of H5N1 and pandemic H1N1 influenza A viruses</article-title>
. <source>J Virol</source>
<volume>89</volume>
:<fpage>7224</fpage>
–<lpage>7234</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.00585-15</pub-id>
.<pub-id pub-id-type="pmid">25948745</pub-id>
</mixed-citation>
</ref>
<ref id="B25"><label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rockman</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Brown</surname>
<given-names>LE</given-names>
</name>
, <name name-style="western"><surname>Barr</surname>
<given-names>IG</given-names>
</name>
, <name name-style="western"><surname>Gilbertson</surname>
<given-names>B</given-names>
</name>
, <name name-style="western"><surname>Lowther</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Kachurin</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Kachurina</surname>
<given-names>O</given-names>
</name>
, <name name-style="western"><surname>Klippel</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Bodle</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Pearse</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Middleton</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine</article-title>
. <source>J Virol</source>
<volume>87</volume>
:<fpage>3053</fpage>
–<lpage>3061</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.02434-12</pub-id>
.<pub-id pub-id-type="pmid">23283953</pub-id>
</mixed-citation>
</ref>
<ref id="B26"><label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname>
<given-names>GE</given-names>
</name>
, <name name-style="western"><surname>Sun</surname>
<given-names>X</given-names>
</name>
, <name name-style="western"><surname>Bai</surname>
<given-names>Y</given-names>
</name>
, <name name-style="western"><surname>Liu</surname>
<given-names>YV</given-names>
</name>
, <name name-style="western"><surname>Massare</surname>
<given-names>MJ</given-names>
</name>
, <name name-style="western"><surname>Pearce</surname>
<given-names>MB</given-names>
</name>
, <name name-style="western"><surname>Belser</surname>
<given-names>JA</given-names>
</name>
, <name name-style="western"><surname>Maines</surname>
<given-names>TR</given-names>
</name>
, <name name-style="western"><surname>Creager</surname>
<given-names>HM</given-names>
</name>
, <name name-style="western"><surname>Glenn</surname>
<given-names>GM</given-names>
</name>
, <name name-style="western"><surname>Flyer</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Pushko</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Levine</surname>
<given-names>MZ</given-names>
</name>
, <name name-style="western"><surname>Tumpey</surname>
<given-names>TM</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets</article-title>
. <source>Virology</source>
<volume>509</volume>
:<fpage>90</fpage>
–<lpage>97</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.virol.2017.06.006</pub-id>
.<pub-id pub-id-type="pmid">28624679</pub-id>
</mixed-citation>
</ref>
<ref id="B27"><label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Couch</surname>
<given-names>RB</given-names>
</name>
, <name name-style="western"><surname>Kasel</surname>
<given-names>JA</given-names>
</name>
, <name name-style="western"><surname>Gerin</surname>
<given-names>JL</given-names>
</name>
, <name name-style="western"><surname>Schulman</surname>
<given-names>JL</given-names>
</name>
, <name name-style="western"><surname>Kilbourne</surname>
<given-names>ED</given-names>
</name>
</person-group>
<year>1974</year>
<article-title>Induction of partial immunity to influenza by a neuraminidase-specific vaccine</article-title>
. <source>J Infect Dis</source>
<volume>129</volume>
:<fpage>411</fpage>
–<lpage>420</lpage>
. doi:<pub-id pub-id-type="doi">10.1093/infdis/129.4.411</pub-id>
.<pub-id pub-id-type="pmid">4593871</pub-id>
</mixed-citation>
</ref>
<ref id="B28"><label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname>
<given-names>BR</given-names>
</name>
, <name name-style="western"><surname>Kasel</surname>
<given-names>JA</given-names>
</name>
, <name name-style="western"><surname>Chanock</surname>
<given-names>RM</given-names>
</name>
</person-group>
<year>1972</year>
<article-title>Association of serum anti-neuraminidase antibody with resistance to influenza in man</article-title>
. <source>N Engl J Med</source>
<volume>286</volume>
:<fpage>1329</fpage>
–<lpage>1332</lpage>
. doi:<pub-id pub-id-type="doi">10.1056/NEJM197206222862502</pub-id>
.<pub-id pub-id-type="pmid">5027388</pub-id>
</mixed-citation>
</ref>
<ref id="B29"><label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monto</surname>
<given-names>AS</given-names>
</name>
, <name name-style="western"><surname>Petrie</surname>
<given-names>JG</given-names>
</name>
, <name name-style="western"><surname>Cross</surname>
<given-names>RT</given-names>
</name>
, <name name-style="western"><surname>Johnson</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Liu</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Zhong</surname>
<given-names>W</given-names>
</name>
, <name name-style="western"><surname>Levine</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Katz</surname>
<given-names>JM</given-names>
</name>
, <name name-style="western"><surname>Ohmit</surname>
<given-names>SE</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Antibody to influenza virus neuraminidase: an independent correlate of protection</article-title>
. <source>J Infect Dis</source>
<volume>212</volume>
:<fpage>1191</fpage>
–<lpage>1199</lpage>
. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiv195</pub-id>
.<pub-id pub-id-type="pmid">25858957</pub-id>
</mixed-citation>
</ref>
<ref id="B30"><label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Memoli</surname>
<given-names>MJ</given-names>
</name>
, <name name-style="western"><surname>Shaw</surname>
<given-names>PA</given-names>
</name>
, <name name-style="western"><surname>Han</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Czajkowski</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Reed</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Athota</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Bristol</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Fargis</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Risos</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Powers</surname>
<given-names>JH</given-names>
</name>
, <name name-style="western"><surname>Davey</surname>
<given-names>RT</given-names>
</name>
, <name name-style="western"><surname>Taubenberger</surname>
<given-names>JK</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model</article-title>
. <source>mBio</source>
<volume>7</volume>
:<elocation-id>e00417-16</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1128/mBio.00417-16</pub-id>
.<pub-id pub-id-type="pmid">27094330</pub-id>
</mixed-citation>
</ref>
<ref id="B31"><label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulman</surname>
<given-names>JL</given-names>
</name>
</person-group>
<year>1969</year>
<article-title>The role of antineuraminidase antibody in immunity to influenza virus infection</article-title>
. <source>Bull World Health Organ</source>
<volume>41</volume>
:<fpage>647</fpage>
–<lpage>650</lpage>
.<pub-id pub-id-type="pmid">5309490</pub-id>
</mixed-citation>
</ref>
<ref id="B32"><label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monto</surname>
<given-names>AS</given-names>
</name>
, <name name-style="western"><surname>Kendal</surname>
<given-names>AP</given-names>
</name>
</person-group>
<year>1973</year>
<article-title>Effect of neuraminidase antibody on Hong Kong influenza</article-title>
. <source>Lancet</source>
<volume>i</volume>
:<fpage>623</fpage>
–<lpage>625</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(73)92196-X</pub-id>
.</mixed-citation>
</ref>
<ref id="B33"><label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Wang</surname>
<given-names>TT</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Why do influenza virus subtypes die out? A hypothesis</article-title>
. <source>mBio</source>
<volume>2</volume>
:<elocation-id>e00150-11</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1128/mBio.00150-11</pub-id>
.<pub-id pub-id-type="pmid">21878571</pub-id>
</mixed-citation>
</ref>
<ref id="B34"><label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandbulte</surname>
<given-names>MR</given-names>
</name>
, <name name-style="western"><surname>Westgeest</surname>
<given-names>KB</given-names>
</name>
, <name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Xu</surname>
<given-names>X</given-names>
</name>
, <name name-style="western"><surname>Klimov</surname>
<given-names>AI</given-names>
</name>
, <name name-style="western"><surname>Russell</surname>
<given-names>CA</given-names>
</name>
, <name name-style="western"><surname>Burke</surname>
<given-names>DF</given-names>
</name>
, <name name-style="western"><surname>Smith</surname>
<given-names>DJ</given-names>
</name>
, <name name-style="western"><surname>Fouchier</surname>
<given-names>RA</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses</article-title>
. <source>Proc Natl Acad Sci U S A</source>
<volume>108</volume>
:<fpage>20748</fpage>
–<lpage>20753</lpage>
. doi:<pub-id pub-id-type="doi">10.1073/pnas.1113801108</pub-id>
.<pub-id pub-id-type="pmid">22143798</pub-id>
</mixed-citation>
</ref>
<ref id="B35"><label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Yang</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Shore</surname>
<given-names>DA</given-names>
</name>
, <name name-style="western"><surname>Garten</surname>
<given-names>RJ</given-names>
</name>
, <name name-style="western"><surname>Couzens</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Jiang</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Carney</surname>
<given-names>PJ</given-names>
</name>
, <name name-style="western"><surname>Villanueva</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Stevens</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers</article-title>
. <source>Nat Commun</source>
<volume>6</volume>
:<fpage>6114</fpage>
. doi:<pub-id pub-id-type="doi">10.1038/ncomms7114</pub-id>
.<pub-id pub-id-type="pmid">25668439</pub-id>
</mixed-citation>
</ref>
<ref id="B36"><label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venkatramani</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Bochkareva</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Lee</surname>
<given-names>JT</given-names>
</name>
, <name name-style="western"><surname>Gulati</surname>
<given-names>U</given-names>
</name>
, <name name-style="western"><surname>Graeme Laver</surname>
<given-names>W</given-names>
</name>
, <name name-style="western"><surname>Bochkarev</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Air</surname>
<given-names>GM</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex</article-title>
. <source>J Mol Biol</source>
<volume>356</volume>
:<fpage>651</fpage>
–<lpage>663</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.jmb.2005.11.061</pub-id>
.<pub-id pub-id-type="pmid">16384583</pub-id>
</mixed-citation>
</ref>
<ref id="B37"><label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Air</surname>
<given-names>GM</given-names>
</name>
, <name name-style="western"><surname>Els</surname>
<given-names>MC</given-names>
</name>
, <name name-style="western"><surname>Brown</surname>
<given-names>LE</given-names>
</name>
, <name name-style="western"><surname>Laver</surname>
<given-names>WG</given-names>
</name>
, <name name-style="western"><surname>Webster</surname>
<given-names>RG</given-names>
</name>
</person-group>
<year>1985</year>
<article-title>Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase</article-title>
. <source>Virology</source>
<volume>145</volume>
:<fpage>237</fpage>
–<lpage>248</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/0042-6822(85)90157-6</pub-id>
.<pub-id pub-id-type="pmid">2411049</pub-id>
</mixed-citation>
</ref>
<ref id="B38"><label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colman</surname>
<given-names>PM</given-names>
</name>
, <name name-style="western"><surname>Tulip</surname>
<given-names>WR</given-names>
</name>
, <name name-style="western"><surname>Varghese</surname>
<given-names>JN</given-names>
</name>
, <name name-style="western"><surname>Tulloch</surname>
<given-names>PA</given-names>
</name>
, <name name-style="western"><surname>Baker</surname>
<given-names>AT</given-names>
</name>
, <name name-style="western"><surname>Laver</surname>
<given-names>WG</given-names>
</name>
, <name name-style="western"><surname>Air</surname>
<given-names>GM</given-names>
</name>
, <name name-style="western"><surname>Webster</surname>
<given-names>RG</given-names>
</name>
</person-group>
<year>1989</year>
<article-title>Three-dimensional structures of influenza virus neuraminidase-antibody complexes</article-title>
. <source>Philos Trans R Soc Lond B Biol Sci</source>
<volume>323</volume>
:<fpage>511</fpage>
–<lpage>518</lpage>
.<pub-id pub-id-type="pmid">2569208</pub-id>
</mixed-citation>
</ref>
<ref id="B39"><label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname>
<given-names>JT</given-names>
</name>
, <name name-style="western"><surname>Air</surname>
<given-names>GM</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal antibody Mem5</article-title>
. <source>Virology</source>
<volume>345</volume>
:<fpage>424</fpage>
–<lpage>433</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.virol.2005.10.014</pub-id>
.<pub-id pub-id-type="pmid">16297424</pub-id>
</mixed-citation>
</ref>
<ref id="B40"><label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname>
<given-names>JT</given-names>
</name>
, <name name-style="western"><surname>Air</surname>
<given-names>GM</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10</article-title>
. <source>Virology</source>
<volume>300</volume>
:<fpage>255</fpage>
–<lpage>268</lpage>
. doi:<pub-id pub-id-type="doi">10.1006/viro.2002.1564</pub-id>
.<pub-id pub-id-type="pmid">12350356</pub-id>
</mixed-citation>
</ref>
<ref id="B41"><label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nuss</surname>
<given-names>JM</given-names>
</name>
, <name name-style="western"><surname>Whitaker</surname>
<given-names>PB</given-names>
</name>
, <name name-style="western"><surname>Air</surname>
<given-names>GM</given-names>
</name>
</person-group>
<year>1993</year>
<article-title>Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase</article-title>
. <source>Proteins</source>
<volume>15</volume>
:<fpage>121</fpage>
–<lpage>132</lpage>
. doi:<pub-id pub-id-type="doi">10.1002/prot.340150204</pub-id>
.<pub-id pub-id-type="pmid">7680132</pub-id>
</mixed-citation>
</ref>
<ref id="B42"><label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansson</surname>
<given-names>BE</given-names>
</name>
, <name name-style="western"><surname>Moran</surname>
<given-names>TM</given-names>
</name>
, <name name-style="western"><surname>Kilbourne</surname>
<given-names>ED</given-names>
</name>
</person-group>
<year>1987</year>
<article-title>Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins</article-title>
. <source>Proc Natl Acad Sci U S A</source>
<volume>84</volume>
:<fpage>6869</fpage>
–<lpage>6873</lpage>
. doi:<pub-id pub-id-type="doi">10.1073/pnas.84.19.6869</pub-id>
.<pub-id pub-id-type="pmid">2958849</pub-id>
</mixed-citation>
</ref>
<ref id="B43"><label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansson</surname>
<given-names>BE</given-names>
</name>
, <name name-style="western"><surname>Kilbourne</surname>
<given-names>ED</given-names>
</name>
</person-group>
<year>1993</year>
<article-title>Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition</article-title>
. <source>J Virol</source>
<volume>67</volume>
:<fpage>5721</fpage>
–<lpage>5723</lpage>
.<pub-id pub-id-type="pmid">8371337</pub-id>
</mixed-citation>
</ref>
<ref id="B44"><label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilbourne</surname>
<given-names>ED</given-names>
</name>
, <name name-style="western"><surname>Couch</surname>
<given-names>RB</given-names>
</name>
, <name name-style="western"><surname>Kasel</surname>
<given-names>JA</given-names>
</name>
, <name name-style="western"><surname>Keitel</surname>
<given-names>WA</given-names>
</name>
, <name name-style="western"><surname>Cate</surname>
<given-names>TR</given-names>
</name>
, <name name-style="western"><surname>Quarles</surname>
<given-names>JH</given-names>
</name>
, <name name-style="western"><surname>Grajower</surname>
<given-names>B</given-names>
</name>
, <name name-style="western"><surname>Pokorny</surname>
<given-names>BA</given-names>
</name>
, <name name-style="western"><surname>Johansson</surname>
<given-names>BE</given-names>
</name>
</person-group>
<year>1995</year>
<article-title>Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans</article-title>
. <source>Vaccine</source>
<volume>13</volume>
:<fpage>1799</fpage>
–<lpage>1803</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/0264-410X(95)00127-M</pub-id>
.<pub-id pub-id-type="pmid">8701596</pub-id>
</mixed-citation>
</ref>
<ref id="B45"><label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nachbagauer</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Wohlbold</surname>
<given-names>TJ</given-names>
</name>
, <name name-style="western"><surname>Hirsh</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Hai</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Sjursen</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Cox</surname>
<given-names>RJ</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans</article-title>
. <source>J Virol</source>
<volume>88</volume>
:<fpage>13260</fpage>
–<lpage>13268</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.02133-14</pub-id>
.<pub-id pub-id-type="pmid">25210189</pub-id>
</mixed-citation>
</ref>
<ref id="B46"><label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Powers</surname>
<given-names>DC</given-names>
</name>
, <name name-style="western"><surname>Kilbourne</surname>
<given-names>ED</given-names>
</name>
, <name name-style="western"><surname>Johansson</surname>
<given-names>BE</given-names>
</name>
</person-group>
<year>1996</year>
<article-title>Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults</article-title>
. <source>Clin Diagn Lab Immunol</source>
<volume>3</volume>
:<fpage>511</fpage>
–<lpage>516</lpage>
.<pub-id pub-id-type="pmid">8877127</pub-id>
</mixed-citation>
</ref>
<ref id="B47"><label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laguio-Vila</surname>
<given-names>MR</given-names>
</name>
, <name name-style="western"><surname>Thompson</surname>
<given-names>MG</given-names>
</name>
, <name name-style="western"><surname>Reynolds</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Spencer</surname>
<given-names>SM</given-names>
</name>
, <name name-style="western"><surname>Gaglani</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Naleway</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Ball</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Bozeman</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Baker</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Martínez-Sobrido</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Levine</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Katz</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Fry</surname>
<given-names>AM</given-names>
</name>
, <name name-style="western"><surname>Treanor</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010–2011 trivalent inactivated influenza vaccination in healthcare personnel</article-title>
. <source>Open Forum Infect Dis</source>
<volume>2</volume>
:<fpage>ofu115</fpage>
. doi:<pub-id pub-id-type="doi">10.1093/ofid/ofu115</pub-id>
.<pub-id pub-id-type="pmid">25884004</pub-id>
</mixed-citation>
</ref>
<ref id="B48"><label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Couch</surname>
<given-names>RB</given-names>
</name>
, <name name-style="western"><surname>Atmar</surname>
<given-names>RL</given-names>
</name>
, <name name-style="western"><surname>Keitel</surname>
<given-names>WA</given-names>
</name>
, <name name-style="western"><surname>Quarles</surname>
<given-names>JM</given-names>
</name>
, <name name-style="western"><surname>Wells</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Arden</surname>
<given-names>N</given-names>
</name>
, <name name-style="western"><surname>Niño</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines</article-title>
. <source>Vaccine</source>
<volume>31</volume>
:<fpage>190</fpage>
–<lpage>195</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.10.065</pub-id>
.<pub-id pub-id-type="pmid">23107591</pub-id>
</mixed-citation>
</ref>
<ref id="B49"><label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hassantoufighi</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Zhang</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Sandbulte</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Manischewitz</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>King</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Golding</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Straight</surname>
<given-names>TM</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses</article-title>
. <source>Vaccine</source>
<volume>28</volume>
:<fpage>790</fpage>
–<lpage>797</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2009.10.066</pub-id>
.<pub-id pub-id-type="pmid">19887135</pub-id>
</mixed-citation>
</ref>
<ref id="B50"><label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cate</surname>
<given-names>TR</given-names>
</name>
, <name name-style="western"><surname>Rayford</surname>
<given-names>Y</given-names>
</name>
, <name name-style="western"><surname>Niño</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Winokur</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Brady</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Belshe</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Chen</surname>
<given-names>W</given-names>
</name>
, <name name-style="western"><surname>Atmar</surname>
<given-names>RL</given-names>
</name>
, <name name-style="western"><surname>Couch</surname>
<given-names>RB</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects</article-title>
. <source>Vaccine</source>
<volume>28</volume>
:<fpage>2076</fpage>
–<lpage>2079</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2009.12.041</pub-id>
.<pub-id pub-id-type="pmid">20044052</pub-id>
</mixed-citation>
</ref>
<ref id="B51"><label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Couch</surname>
<given-names>RB</given-names>
</name>
, <name name-style="western"><surname>Atmar</surname>
<given-names>RL</given-names>
</name>
, <name name-style="western"><surname>Franco</surname>
<given-names>LM</given-names>
</name>
, <name name-style="western"><surname>Quarles</surname>
<given-names>JM</given-names>
</name>
, <name name-style="western"><surname>Wells</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Arden</surname>
<given-names>N</given-names>
</name>
, <name name-style="western"><surname>Niño</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Belmont</surname>
<given-names>JW</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase</article-title>
. <source>J Infect Dis</source>
<volume>207</volume>
:<fpage>974</fpage>
–<lpage>981</lpage>
. doi:<pub-id pub-id-type="doi">10.1093/infdis/jis935</pub-id>
.<pub-id pub-id-type="pmid">23307936</pub-id>
</mixed-citation>
</ref>
<ref id="B52"><label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Getie-Kebtie</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Sultana</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Alterman</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines</article-title>
. <source>Influenza Other Respir Viruses</source>
<volume>7</volume>
:<fpage>521</fpage>
–<lpage>530</lpage>
. doi:<pub-id pub-id-type="doi">10.1111/irv.12001</pub-id>
.<pub-id pub-id-type="pmid">22943763</pub-id>
</mixed-citation>
</ref>
<ref id="B53"><label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sultana</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Yang</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Getie-Kebtie</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Couzens</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Markoff</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Alterman</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Stability of neuraminidase in inactivated influenza vaccines</article-title>
. <source>Vaccine</source>
<volume>32</volume>
:<fpage>2225</fpage>
–<lpage>2230</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2014.01.078</pub-id>
.<pub-id pub-id-type="pmid">24613525</pub-id>
</mixed-citation>
</ref>
<ref id="B54"><label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Velden</surname>
<given-names>MV</given-names>
</name>
, <name name-style="western"><surname>Fritz</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Pöllabauer</surname>
<given-names>EM</given-names>
</name>
, <name name-style="western"><surname>Portsmouth</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Howard</surname>
<given-names>MK</given-names>
</name>
, <name name-style="western"><surname>Kreil</surname>
<given-names>TR</given-names>
</name>
, <name name-style="western"><surname>Dvorak</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Fritsch</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Vesikari</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Diez-Domingo</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Richmond</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Lee</surname>
<given-names>BW</given-names>
</name>
, <name name-style="western"><surname>Kistner</surname>
<given-names>O</given-names>
</name>
, <name name-style="western"><surname>Ehrlich</surname>
<given-names>HJ</given-names>
</name>
, <name name-style="western"><surname>Barrett</surname>
<given-names>PN</given-names>
</name>
, <name name-style="western"><surname>Aichinger</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Safety and immunogenicity of a Vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population</article-title>
. <source>J Infect Dis</source>
<volume>209</volume>
:<fpage>12</fpage>
–<lpage>23</lpage>
. doi:<pub-id pub-id-type="doi">10.1093/infdis/jit498</pub-id>
.<pub-id pub-id-type="pmid">24041789</pub-id>
</mixed-citation>
</ref>
<ref id="B55"><label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben-Yehuda</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Joseph</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Barenholz</surname>
<given-names>Y</given-names>
</name>
, <name name-style="western"><surname>Zeira</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Even-Chen</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Louria-Hayon</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Babai</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Zakay-Rones</surname>
<given-names>Z</given-names>
</name>
, <name name-style="western"><surname>Greenbaum</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Galprin</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Glück</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Zurbriggen</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Kedar</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents</article-title>
. <source>Vaccine</source>
<volume>21</volume>
:<fpage>3169</fpage>
–<lpage>3178</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/S0264-410X(03)00251-2</pub-id>
.<pub-id pub-id-type="pmid">12804845</pub-id>
</mixed-citation>
</ref>
<ref id="B56"><label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansson</surname>
<given-names>BE</given-names>
</name>
, <name name-style="western"><surname>Matthews</surname>
<given-names>JT</given-names>
</name>
, <name name-style="western"><surname>Kilbourne</surname>
<given-names>ED</given-names>
</name>
</person-group>
<year>1998</year>
<article-title>Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response</article-title>
. <source>Vaccine</source>
<volume>16</volume>
:<fpage>1009</fpage>
–<lpage>1015</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/S0264-410X(97)00279-X</pub-id>
.<pub-id pub-id-type="pmid">9682352</pub-id>
</mixed-citation>
</ref>
<ref id="B57"><label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalakouras</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Smith</surname>
<given-names>BJ</given-names>
</name>
, <name name-style="western"><surname>Platis</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Cox</surname>
<given-names>MM</given-names>
</name>
, <name name-style="western"><surname>Labrou</surname>
<given-names>NE</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Development of recombinant protein-based influenza vaccine. Expression and affinity purification of H1N1 influenza virus neuraminidase</article-title>
. <source>J Chromatogr A</source>
<volume>1136</volume>
:<fpage>48</fpage>
–<lpage>56</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.chroma.2006.09.067</pub-id>
.<pub-id pub-id-type="pmid">17046775</pub-id>
</mixed-citation>
</ref>
<ref id="B58"><label>58.</label>
<mixed-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Schiff</surname>
<given-names>GKE</given-names>
</name>
, <name name-style="western"><surname>Smith</surname>
<given-names>G</given-names>
</name>
, <name name-style="western"><surname>Hackett</surname>
<given-names>C</given-names>
</name>
, <name name-style="western"><surname>Manoff</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Matthews</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Johansson</surname>
<given-names>B</given-names>
</name>
</person-group>
<source>Phase 2 clinical evaluation of an influenza A virus recombinant N2 neuraminidase vaccine</source>
. <conf-name>Presented at The First European Influenza Congress, Hersonessos</conf-name>
, <conf-loc>Crete, Greece</conf-loc>
, <conf-date>23–28 September 2000</conf-date>
.</mixed-citation>
</ref>
<ref id="B59"><label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halbherr</surname>
<given-names>SJ</given-names>
</name>
, <name name-style="western"><surname>Ludersdorfer</surname>
<given-names>TH</given-names>
</name>
, <name name-style="western"><surname>Ricklin</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Locher</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Berger Rentsch</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Summerfield</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Zimmer</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Biological and protective properties of immune sera directed to influenza virus neuraminidase</article-title>
. <source>J Virol</source>
<volume>89</volume>
:<fpage>1550</fpage>
–<lpage>1563</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.02949-14</pub-id>
.<pub-id pub-id-type="pmid">25392225</pub-id>
</mixed-citation>
</ref>
<ref id="B60"><label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doyle</surname>
<given-names>TM</given-names>
</name>
, <name name-style="western"><surname>Hashem</surname>
<given-names>AM</given-names>
</name>
, <name name-style="western"><surname>Li</surname>
<given-names>C</given-names>
</name>
, <name name-style="western"><surname>Van Domselaar</surname>
<given-names>G</given-names>
</name>
, <name name-style="western"><surname>Larocque</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Wang</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Smith</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Cyr</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Farnsworth</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>He</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Hurt</surname>
<given-names>AC</given-names>
</name>
, <name name-style="western"><surname>Brown</surname>
<given-names>EG</given-names>
</name>
, <name name-style="western"><surname>Li</surname>
<given-names>X</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Universal anti-neuraminidase antibody inhibiting all influenza A subtypes</article-title>
. <source>Antiviral Res</source>
<volume>100</volume>
:<fpage>567</fpage>
–<lpage>574</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.antiviral.2013.09.018</pub-id>
.<pub-id pub-id-type="pmid">24091204</pub-id>
</mixed-citation>
</ref>
<ref id="B61"><label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doyle</surname>
<given-names>TM</given-names>
</name>
, <name name-style="western"><surname>Li</surname>
<given-names>C</given-names>
</name>
, <name name-style="western"><surname>Bucher</surname>
<given-names>DJ</given-names>
</name>
, <name name-style="western"><surname>Hashem</surname>
<given-names>AM</given-names>
</name>
, <name name-style="western"><surname>Van Domselaar</surname>
<given-names>G</given-names>
</name>
, <name name-style="western"><surname>Wang</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Farnsworth</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>She</surname>
<given-names>YM</given-names>
</name>
, <name name-style="western"><surname>Cyr</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>He</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Brown</surname>
<given-names>EG</given-names>
</name>
, <name name-style="western"><surname>Hurt</surname>
<given-names>AC</given-names>
</name>
, <name name-style="western"><surname>Li</surname>
<given-names>X</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains</article-title>
. <source>Biochem Biophys Res Commun</source>
<volume>441</volume>
:<fpage>226</fpage>
–<lpage>229</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.bbrc.2013.10.041</pub-id>
.<pub-id pub-id-type="pmid">24140051</pub-id>
</mixed-citation>
</ref>
<ref id="B62"><label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilbourne</surname>
<given-names>ED</given-names>
</name>
, <name name-style="western"><surname>Johansson</surname>
<given-names>BE</given-names>
</name>
, <name name-style="western"><surname>Grajower</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>1990</year>
<article-title>Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins</article-title>
. <source>Proc Natl Acad Sci U S A</source>
<volume>87</volume>
:<fpage>786</fpage>
–<lpage>790</lpage>
. doi:<pub-id pub-id-type="doi">10.1073/pnas.87.2.786</pub-id>
.<pub-id pub-id-type="pmid">2300562</pub-id>
</mixed-citation>
</ref>
<ref id="B63"><label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westgeest</surname>
<given-names>KB</given-names>
</name>
, <name name-style="western"><surname>Bestebroer</surname>
<given-names>TM</given-names>
</name>
, <name name-style="western"><surname>Spronken</surname>
<given-names>MI</given-names>
</name>
, <name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Couzens</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Osterhaus</surname>
<given-names>AD</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Fouchier</surname>
<given-names>RA</given-names>
</name>
, <name name-style="western"><surname>de Graaf</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses</article-title>
. <source>J Virol Methods</source>
<volume>217</volume>
:<fpage>55</fpage>
–<lpage>63</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.jviromet.2015.02.014</pub-id>
.<pub-id pub-id-type="pmid">25712563</pub-id>
</mixed-citation>
</ref>
<ref id="B64"><label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajendran</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Nachbagauer</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Ermler</surname>
<given-names>ME</given-names>
</name>
, <name name-style="western"><surname>Bunduc</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Amanat</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Izikson</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Cox</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and enzyme inhibition: evidence for original antigenic sin</article-title>
. <source>mBio</source>
<volume>8</volume>
:<elocation-id>e02281-16</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1128/mBio.02281-16</pub-id>
.<pub-id pub-id-type="pmid">28325769</pub-id>
</mixed-citation>
</ref>
<ref id="B65"><label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nachbagauer</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Choi</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Hirsh</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Margine</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Iida</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Barrera</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Ferres</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Albrecht</surname>
<given-names>RA</given-names>
</name>
, <name name-style="western"><surname>García-Sastre</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Bouvier</surname>
<given-names>NM</given-names>
</name>
, <name name-style="western"><surname>Ito</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Medina</surname>
<given-names>RA</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins</article-title>
. <source>Nat Immunol</source>
<volume>18</volume>
:<fpage>464</fpage>
–<lpage>473</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/ni.3684</pub-id>
.<pub-id pub-id-type="pmid">28192418</pub-id>
</mixed-citation>
</ref>
<ref id="B66"><label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohr</surname>
<given-names>PG</given-names>
</name>
, <name name-style="western"><surname>Deng</surname>
<given-names>YM</given-names>
</name>
, <name name-style="western"><surname>McKimm-Breschkin</surname>
<given-names>JL</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding</article-title>
. <source>Virol J</source>
<volume>12</volume>
:<fpage>67</fpage>
. doi:<pub-id pub-id-type="doi">10.1186/s12985-015-0295-3</pub-id>
.<pub-id pub-id-type="pmid">25896455</pub-id>
</mixed-citation>
</ref>
<ref id="B67"><label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname>
<given-names>YP</given-names>
</name>
, <name name-style="western"><surname>Gregory</surname>
<given-names>V</given-names>
</name>
, <name name-style="western"><surname>Collins</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Kloess</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Wharton</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Cattle</surname>
<given-names>N</given-names>
</name>
, <name name-style="western"><surname>Lackenby</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Daniels</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Hay</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?</article-title>
<source>J Virol</source>
<volume>84</volume>
:<fpage>6769</fpage>
–<lpage>6781</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.00458-10</pub-id>
.<pub-id pub-id-type="pmid">20410266</pub-id>
</mixed-citation>
</ref>
<ref id="B68"><label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mögling</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Richard</surname>
<given-names>MJ</given-names>
</name>
, <name name-style="western"><surname>Vliet</surname>
<given-names>SV</given-names>
</name>
, <name name-style="western"><surname>Beek</surname>
<given-names>RV</given-names>
</name>
, <name name-style="western"><surname>Schrauwen</surname>
<given-names>EJA</given-names>
</name>
, <name name-style="western"><surname>Spronken</surname>
<given-names>MI</given-names>
</name>
, <name name-style="western"><surname>Rimmelzwaan</surname>
<given-names>GF</given-names>
</name>
, <name name-style="western"><surname>Fouchier</surname>
<given-names>RAM</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Neuraminidase-mediated haemagglutination of recent human influenza A(H3N2) viruses is determined by arginine 150 flanking the neuraminidase catalytic site</article-title>
. <source>J Gen Virol</source>
<volume>98</volume>
:<fpage>1274</fpage>
–<lpage>1281</lpage>
. doi:<pub-id pub-id-type="doi">10.1099/jgv.0.000809</pub-id>
.<pub-id pub-id-type="pmid">28612701</pub-id>
</mixed-citation>
</ref>
<ref id="B69"><label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dilillo</surname>
<given-names>DJ</given-names>
</name>
, <name name-style="western"><surname>Tan</surname>
<given-names>GS</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Ravetch</surname>
<given-names>JV</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo</article-title>
. <source>Nat Med</source>
<volume>20</volume>
:<fpage>143</fpage>
–<lpage>151</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/nm.3443</pub-id>
.<pub-id pub-id-type="pmid">24412922</pub-id>
</mixed-citation>
</ref>
<ref id="B70"><label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jegaskanda</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Reading</surname>
<given-names>PC</given-names>
</name>
, <name name-style="western"><surname>Kent</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine</article-title>
. <source>J Immunol</source>
<volume>193</volume>
:<fpage>469</fpage>
–<lpage>475</lpage>
. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1400432</pub-id>
.<pub-id pub-id-type="pmid">24994909</pub-id>
</mixed-citation>
</ref>
<ref id="B71"><label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Vries</surname>
<given-names>RD</given-names>
</name>
, <name name-style="western"><surname>Nieuwkoop</surname>
<given-names>NJ</given-names>
</name>
, <name name-style="western"><surname>van der Klis</surname>
<given-names>FRM</given-names>
</name>
, <name name-style="western"><surname>Koopmans</surname>
<given-names>MPG</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Rimmelzwaan</surname>
<given-names>GF</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Primary human influenza B virus infection induces cross-lineage hemagglutinin stalk-specific antibodies mediating antibody-dependent cellular cytoxicity [<italic>sic</italic>
]</article-title>
. <source>J Infect Dis</source>
<volume>217</volume>
:<fpage>3</fpage>
–<lpage>11</lpage>
. doi:<pub-id pub-id-type="doi">10.1093/infdis/jix546</pub-id>
.<pub-id pub-id-type="pmid">29294018</pub-id>
</mixed-citation>
</ref>
<ref id="B72"><label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Vries</surname>
<given-names>RD</given-names>
</name>
, <name name-style="western"><surname>Nieuwkoop</surname>
<given-names>NJ</given-names>
</name>
, <name name-style="western"><surname>Pronk</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>de Bruin</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Leroux-Roels</surname>
<given-names>G</given-names>
</name>
, <name name-style="western"><surname>Huijskens</surname>
<given-names>EGW</given-names>
</name>
, <name name-style="western"><surname>van Binnendijk</surname>
<given-names>RS</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Koopmans</surname>
<given-names>MPG</given-names>
</name>
, <name name-style="western"><surname>Rimmelzwaan</surname>
<given-names>GF</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Influenza virus-specific antibody dependent cellular cytoxicity [<italic>sic</italic>
] induced by vaccination or natural infection</article-title>
. <source>Vaccine</source>
<volume>35</volume>
:<fpage>238</fpage>
–<lpage>247</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.11.082</pub-id>
.<pub-id pub-id-type="pmid">27914742</pub-id>
</mixed-citation>
</ref>
<ref id="B73"><label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leon</surname>
<given-names>PE</given-names>
</name>
, <name name-style="western"><surname>He</surname>
<given-names>W</given-names>
</name>
, <name name-style="western"><surname>Mullarkey</surname>
<given-names>CE</given-names>
</name>
, <name name-style="western"><surname>Bailey</surname>
<given-names>MJ</given-names>
</name>
, <name name-style="western"><surname>Miller</surname>
<given-names>MS</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Tan</surname>
<given-names>GS</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact</article-title>
. <source>Proc Natl Acad Sci U S A</source>
113:E5944–E5951. doi:<pub-id pub-id-type="doi">10.1073/pnas.1613225113</pub-id>
.</mixed-citation>
</ref>
<ref id="B74"><label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cox</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Kwaks</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Brandenburg</surname>
<given-names>B</given-names>
</name>
, <name name-style="western"><surname>Koldijk</surname>
<given-names>MH</given-names>
</name>
, <name name-style="western"><surname>Klaren</surname>
<given-names>V</given-names>
</name>
, <name name-style="western"><surname>Smal</surname>
<given-names>B</given-names>
</name>
, <name name-style="western"><surname>Korse</surname>
<given-names>HJ</given-names>
</name>
, <name name-style="western"><surname>Geelen</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Tettero</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Zuijdgeest</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Stoop</surname>
<given-names>EJ</given-names>
</name>
, <name name-style="western"><surname>Saeland</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Vogels</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Friesen</surname>
<given-names>RH</given-names>
</name>
, <name name-style="western"><surname>Koudstaal</surname>
<given-names>W</given-names>
</name>
, <name name-style="western"><surname>Goudsmit</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>HA antibody-mediated FcγRIIIa activity is both dependent on FcR engagement and interactions between HA and sialic acids</article-title>
. <source>Front Immunol</source>
<volume>7</volume>
:<fpage>399</fpage>
. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2016.00399</pub-id>
.<pub-id pub-id-type="pmid">27746785</pub-id>
</mixed-citation>
</ref>
<ref id="B75"><label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname>
<given-names>W</given-names>
</name>
, <name name-style="western"><surname>Tan</surname>
<given-names>GS</given-names>
</name>
, <name name-style="western"><surname>Mullarkey</surname>
<given-names>CE</given-names>
</name>
, <name name-style="western"><surname>Lee</surname>
<given-names>AJ</given-names>
</name>
, <name name-style="western"><surname>Lam</surname>
<given-names>MM</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Henry</surname>
<given-names>C</given-names>
</name>
, <name name-style="western"><surname>Wilson</surname>
<given-names>PC</given-names>
</name>
, <name name-style="western"><surname>Ashkar</surname>
<given-names>AA</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Miller</surname>
<given-names>MS</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus</article-title>
. <source>Proc Natl Acad Sci U S A</source>
<volume>113</volume>
:<fpage>11931</fpage>
–<lpage>11936</lpage>
. doi:<pub-id pub-id-type="doi">10.1073/pnas.1609316113</pub-id>
.<pub-id pub-id-type="pmid">27698132</pub-id>
</mixed-citation>
</ref>
<ref id="B76"><label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bar-On</surname>
<given-names>Y</given-names>
</name>
, <name name-style="western"><surname>Glasner</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Meningher</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Achdout</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Gur</surname>
<given-names>C</given-names>
</name>
, <name name-style="western"><surname>Lankry</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Vitenshtein</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Meyers</surname>
<given-names>AFA</given-names>
</name>
, <name name-style="western"><surname>Mandelboim</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Mandelboim</surname>
<given-names>O</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses</article-title>
. <source>Cell Rep</source>
<volume>3</volume>
:<fpage>1044</fpage>
–<lpage>1050</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2013.03.034</pub-id>
.<pub-id pub-id-type="pmid">23602571</pub-id>
</mixed-citation>
</ref>
<ref id="B77"><label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bar-On</surname>
<given-names>Y</given-names>
</name>
, <name name-style="western"><surname>Seidel</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Tsukerman</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Mandelboim</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Mandelboim</surname>
<given-names>O</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors</article-title>
. <source>J Infect Dis</source>
<volume>210</volume>
:<fpage>410</fpage>
–<lpage>418</lpage>
. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiu094</pub-id>
.<pub-id pub-id-type="pmid">24532603</pub-id>
</mixed-citation>
</ref>
<ref id="B78"><label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hurwitz</surname>
<given-names>JL</given-names>
</name>
, <name name-style="western"><surname>Hackett</surname>
<given-names>CJ</given-names>
</name>
, <name name-style="western"><surname>McAndrew</surname>
<given-names>EC</given-names>
</name>
, <name name-style="western"><surname>Gerhard</surname>
<given-names>W</given-names>
</name>
</person-group>
<year>1985</year>
<article-title>Murine TH response to influenza virus: recognition of hemagglutinin, neuraminidase, matrix, and nucleoproteins</article-title>
. <source>J Immunol</source>
<volume>134</volume>
:<fpage>1994</fpage>
–<lpage>1998</lpage>
.<pub-id pub-id-type="pmid">3155776</pub-id>
</mixed-citation>
</ref>
<ref id="B79"><label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hackett</surname>
<given-names>CJ</given-names>
</name>
, <name name-style="western"><surname>Horowitz</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Wysocka</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Eisenlohr</surname>
<given-names>LC</given-names>
</name>
</person-group>
<year>1991</year>
<article-title>Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus</article-title>
. <source>J Virol</source>
<volume>65</volume>
:<fpage>672</fpage>
–<lpage>676</lpage>
.<pub-id pub-id-type="pmid">1898970</pub-id>
</mixed-citation>
</ref>
<ref id="B80"><label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carlson</surname>
<given-names>CM</given-names>
</name>
, <name name-style="western"><surname>Turpin</surname>
<given-names>EA</given-names>
</name>
, <name name-style="western"><surname>Moser</surname>
<given-names>LA</given-names>
</name>
, <name name-style="western"><surname>O’Brien</surname>
<given-names>KB</given-names>
</name>
, <name name-style="western"><surname>Cline</surname>
<given-names>TD</given-names>
</name>
, <name name-style="western"><surname>Jones</surname>
<given-names>JC</given-names>
</name>
, <name name-style="western"><surname>Tumpey</surname>
<given-names>TM</given-names>
</name>
, <name name-style="western"><surname>Katz</surname>
<given-names>JM</given-names>
</name>
, <name name-style="western"><surname>Kelley</surname>
<given-names>LA</given-names>
</name>
, <name name-style="western"><surname>Gauldie</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Schultz-Cherry</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Transforming growth factor-β: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis</article-title>
. <source>PLoS Pathog</source>
<volume>6</volume>
:<elocation-id>e1001136</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1001136</pub-id>
.<pub-id pub-id-type="pmid">20949074</pub-id>
</mixed-citation>
</ref>
<ref id="B81"><label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schultz-Cherry</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Hinshaw</surname>
<given-names>VS</given-names>
</name>
</person-group>
<year>1996</year>
<article-title>Influenza virus neuraminidase activates latent transforming growth factor beta</article-title>
. <source>J Virol</source>
<volume>70</volume>
:<fpage>8624</fpage>
–<lpage>8629</lpage>
.<pub-id pub-id-type="pmid">8970987</pub-id>
</mixed-citation>
</ref>
<ref id="B82"><label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Belz</surname>
<given-names>GT</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Viral neuraminidase treatment of dendritic cells enhances antigen-specific CD8(+) T cell proliferation, but does not account for the CD4(+) T cell independence of the CD8(+) T cell response during influenza virus infection</article-title>
. <source>Virology</source>
<volume>286</volume>
:<fpage>403</fpage>
–<lpage>411</lpage>
. doi:<pub-id pub-id-type="doi">10.1006/viro.2001.0992</pub-id>
.<pub-id pub-id-type="pmid">11485408</pub-id>
</mixed-citation>
</ref>
<ref id="B83"><label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells</article-title>
. <source>J Virol</source>
<volume>74</volume>
:<fpage>7738</fpage>
–<lpage>7744</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.74.17.7738-7744.2000</pub-id>
.<pub-id pub-id-type="pmid">10933679</pub-id>
</mixed-citation>
</ref>
<ref id="B84"><label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>McCaffery</surname>
<given-names>JM</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus</article-title>
. <source>J Virol</source>
<volume>74</volume>
:<fpage>5460</fpage>
–<lpage>5469</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.74.12.5460-5469.2000</pub-id>
.<pub-id pub-id-type="pmid">10823850</pub-id>
</mixed-citation>
</ref>
<ref id="B85"><label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babiuk</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Skowronski</surname>
<given-names>DM</given-names>
</name>
, <name name-style="western"><surname>De Serres</surname>
<given-names>G</given-names>
</name>
, <name name-style="western"><surname>HayGlass</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Brunham</surname>
<given-names>RC</given-names>
</name>
, <name name-style="western"><surname>Babiuk</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model</article-title>
. <source>J Med Virol</source>
<volume>72</volume>
:<fpage>138</fpage>
–<lpage>142</lpage>
. doi:<pub-id pub-id-type="doi">10.1002/jmv.10540</pub-id>
.<pub-id pub-id-type="pmid">14635022</pub-id>
</mixed-citation>
</ref>
<ref id="B86"><label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Sultana</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Couzens</surname>
<given-names>LK</given-names>
</name>
, <name name-style="western"><surname>Mindaye</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Assessment of influenza A neuraminidase (subtype N1) potency by ELISA</article-title>
. <source>J Virol Methods</source>
<volume>244</volume>
:<fpage>23</fpage>
–<lpage>28</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.jviromet.2017.02.015</pub-id>
.<pub-id pub-id-type="pmid">28257802</pub-id>
</mixed-citation>
</ref>
<ref id="B87"><label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuck</surname>
<given-names>LR</given-names>
</name>
, <name name-style="western"><surname>Saye</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Loob</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Roth-Eichhorn</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Byrne-Nash</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Rowlen</surname>
<given-names>KL</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>VaxArray assessment of influenza split vaccine potency and stability</article-title>
. <source>Vaccine</source>
<volume>35</volume>
:<fpage>1918</fpage>
–<lpage>1925</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2017.02.028</pub-id>
.<pub-id pub-id-type="pmid">28262335</pub-id>
</mixed-citation>
</ref>
<ref id="B88"><label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solano</surname>
<given-names>MI</given-names>
</name>
, <name name-style="western"><surname>Woolfitt</surname>
<given-names>AR</given-names>
</name>
, <name name-style="western"><surname>Williams</surname>
<given-names>TL</given-names>
</name>
, <name name-style="western"><surname>Pierce</surname>
<given-names>CL</given-names>
</name>
, <name name-style="western"><surname>Gubareva</surname>
<given-names>LV</given-names>
</name>
, <name name-style="western"><surname>Mishin</surname>
<given-names>V</given-names>
</name>
, <name name-style="western"><surname>Barr</surname>
<given-names>JR</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Quantification of influenza neuraminidase activity by ultra-high performance liquid chromatography and isotope dilution mass spectrometry</article-title>
. <source>Anal Chem</source>
<volume>89</volume>
:<fpage>3130</fpage>
–<lpage>3137</lpage>
. doi:<pub-id pub-id-type="doi">10.1021/acs.analchem.6b04902</pub-id>
.<pub-id pub-id-type="pmid">28192976</pub-id>
</mixed-citation>
</ref>
<ref id="B89"><label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouvier</surname>
<given-names>NM</given-names>
</name>
, <name name-style="western"><surname>Lowen</surname>
<given-names>AC</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol</article-title>
. <source>J Virol</source>
<volume>82</volume>
:<fpage>10052</fpage>
–<lpage>10058</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.01226-08</pub-id>
.<pub-id pub-id-type="pmid">18684820</pub-id>
</mixed-citation>
</ref>
<ref id="B90"><label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Couzens</surname>
<given-names>L</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Measuring influenza neuraminidase inhibition antibody titers by enzyme-linked lectin assay</article-title>
. <source>J Vis Exp</source>
<volume>2016</volume>
:<fpage>54573</fpage>
. doi:<pub-id pub-id-type="doi">10.3791/54573</pub-id>
.</mixed-citation>
</ref>
<ref id="B91"><label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandbulte</surname>
<given-names>MR</given-names>
</name>
, <name name-style="western"><surname>Gao</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Straight</surname>
<given-names>TM</given-names>
</name>
, <name name-style="western"><surname>Eichelberger</surname>
<given-names>MC</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens</article-title>
. <source>Influenza Other Respir Viruses</source>
<volume>3</volume>
:<fpage>233</fpage>
–<lpage>240</lpage>
. doi:<pub-id pub-id-type="doi">10.1111/j.1750-2659.2009.00094.x</pub-id>
.<pub-id pub-id-type="pmid">21462400</pub-id>
</mixed-citation>
</ref>
<ref id="B92"><label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobsen</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Rajendran</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Choi</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Sjursen</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Brokstad</surname>
<given-names>KA</given-names>
</name>
, <name name-style="western"><surname>Cox</surname>
<given-names>RJ</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Nachbagauer</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model</article-title>
. <source>mBio</source>
<volume>8</volume>
:<elocation-id>e01463-17</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1128/mBio.01463-17</pub-id>
.<pub-id pub-id-type="pmid">28928215</pub-id>
</mixed-citation>
</ref>
<ref id="B93"><label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gavrilov</surname>
<given-names>V</given-names>
</name>
, <name name-style="western"><surname>Orekov</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Alabanza</surname>
<given-names>C</given-names>
</name>
, <name name-style="western"><surname>Porika</surname>
<given-names>U</given-names>
</name>
, <name name-style="western"><surname>Jiang</surname>
<given-names>H</given-names>
</name>
, <name name-style="western"><surname>Connolly</surname>
<given-names>K</given-names>
</name>
, <name name-style="western"><surname>Pincus</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Influenza virus-like particles as a new tool for vaccine immunogenicity testing: validation of a neuraminidase neutralizing antibody assay</article-title>
. <source>J Virol Methods</source>
<volume>173</volume>
:<fpage>364</fpage>
–<lpage>373</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.jviromet.2011.03.011</pub-id>
.<pub-id pub-id-type="pmid">21419169</pub-id>
</mixed-citation>
</ref>
<ref id="B94"><label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prevato</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Ferlenghi</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Bonci</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Uematsu</surname>
<given-names>Y</given-names>
</name>
, <name name-style="western"><surname>Anselmi</surname>
<given-names>G</given-names>
</name>
, <name name-style="western"><surname>Giusti</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Bertholet</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Legay</surname>
<given-names>F</given-names>
</name>
, <name name-style="western"><surname>Telford</surname>
<given-names>JL</given-names>
</name>
, <name name-style="western"><surname>Settembre</surname>
<given-names>EC</given-names>
</name>
, <name name-style="western"><surname>Maione</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Cozzi</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Expression and characterization of recombinant, tetrameric and enzymatically active influenza neuraminidase for the setup of an enzyme-linked lectin-based assay</article-title>
. <source>PLoS One</source>
<volume>10</volume>
:<elocation-id>e0135474</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0135474</pub-id>
.<pub-id pub-id-type="pmid">26280677</pub-id>
</mixed-citation>
</ref>
<ref id="B95"><label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schotsaert</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Ysenbaert</surname>
<given-names>T</given-names>
</name>
, <name name-style="western"><surname>Smet</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Schepens</surname>
<given-names>B</given-names>
</name>
, <name name-style="western"><surname>Vanderschaeghe</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Stegalkina</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Vogel</surname>
<given-names>TU</given-names>
</name>
, <name name-style="western"><surname>Callewaert</surname>
<given-names>N</given-names>
</name>
, <name name-style="western"><surname>Fiers</surname>
<given-names>W</given-names>
</name>
, <name name-style="western"><surname>Saelens</surname>
<given-names>X</given-names>
</name>
</person-group>
<year>2016</year>
<article-title>Long-lasting cross-protection against influenza A by neuraminidase and M2e-based immunization strategies</article-title>
. <source>Sci Rep</source>
<volume>6</volume>
:<fpage>24402</fpage>
. doi:<pub-id pub-id-type="doi">10.1038/srep24402</pub-id>
.<pub-id pub-id-type="pmid">27072615</pub-id>
</mixed-citation>
</ref>
<ref id="B96"><label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kosik</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Yewdell</surname>
<given-names>JW</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms</article-title>
. <source>Virology</source>
<volume>500</volume>
:<fpage>178</fpage>
–<lpage>183</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.virol.2016.10.024</pub-id>
.<pub-id pub-id-type="pmid">27825034</pub-id>
</mixed-citation>
</ref>
<ref id="B97"><label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prevato</surname>
<given-names>M</given-names>
</name>
, <name name-style="western"><surname>Cozzi</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Pezzicoli</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Taddei</surname>
<given-names>AR</given-names>
</name>
, <name name-style="western"><surname>Ferlenghi</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Nandi</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Montomoli</surname>
<given-names>E</given-names>
</name>
, <name name-style="western"><surname>Settembre</surname>
<given-names>EC</given-names>
</name>
, <name name-style="western"><surname>Bertholet</surname>
<given-names>S</given-names>
</name>
, <name name-style="western"><surname>Bonci</surname>
<given-names>A</given-names>
</name>
, <name name-style="western"><surname>Legay</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>An innovative pseudotypes-based enzyme-linked lectin assay for the measurement of functional anti-neuraminidase antibodies</article-title>
. <source>PLoS One</source>
<volume>10</volume>
:<elocation-id>e0135383</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0135383</pub-id>
.<pub-id pub-id-type="pmid">26267900</pub-id>
</mixed-citation>
</ref>
<ref id="B98"><label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Margine</surname>
<given-names>I</given-names>
</name>
, <name name-style="western"><surname>Palese</surname>
<given-names>P</given-names>
</name>
, <name name-style="western"><surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system</article-title>
. <source>J Vis Exp</source>
<year>2013</year>
:<elocation-id>e51112</elocation-id>
. doi:<pub-id pub-id-type="doi">10.3791/51112</pub-id>
.<pub-id pub-id-type="pmid">24300384</pub-id>
</mixed-citation>
</ref>
<ref id="B99"><label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname>
<given-names>PM</given-names>
</name>
, <name name-style="western"><surname>Attwood</surname>
<given-names>RM</given-names>
</name>
, <name name-style="western"><surname>Mohr</surname>
<given-names>PG</given-names>
</name>
, <name name-style="western"><surname>Barrett</surname>
<given-names>SA</given-names>
</name>
, <name name-style="western"><surname>McKimm-Breschkin</surname>
<given-names>JL</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>A generic system for the expression and purification of soluble and stable influenza neuraminidase</article-title>
. <source>PLoS One</source>
<volume>6</volume>
:<elocation-id>e16284</elocation-id>
. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0016284</pub-id>
.<pub-id pub-id-type="pmid">21326879</pub-id>
</mixed-citation>
</ref>
<ref id="B100"><label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname>
<given-names>X</given-names>
</name>
, <name name-style="western"><surname>Zhu</surname>
<given-names>X</given-names>
</name>
, <name name-style="western"><surname>Dwek</surname>
<given-names>RA</given-names>
</name>
, <name name-style="western"><surname>Stevens</surname>
<given-names>J</given-names>
</name>
, <name name-style="western"><surname>Wilson</surname>
<given-names>IA</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Structural characterization of the 1918 influenza virus H1N1 neuraminidase</article-title>
. <source>J Virol</source>
<volume>82</volume>
:<fpage>10493</fpage>
–<lpage>10501</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.00959-08</pub-id>
.<pub-id pub-id-type="pmid">18715929</pub-id>
</mixed-citation>
</ref>
<ref id="B101"><label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paules</surname>
<given-names>CI</given-names>
</name>
, <name name-style="western"><surname>Marston</surname>
<given-names>HD</given-names>
</name>
, <name name-style="western"><surname>Eisinger</surname>
<given-names>RW</given-names>
</name>
, <name name-style="western"><surname>Baltimore</surname>
<given-names>D</given-names>
</name>
, <name name-style="western"><surname>Fauci</surname>
<given-names>AS</given-names>
</name>
</person-group>
<year>2017</year>
<article-title>The pathway to a universal influenza vaccine</article-title>
. <source>Immunity</source>
<volume>47</volume>
:<fpage>599</fpage>
–<lpage>603</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2017.09.007</pub-id>
.<pub-id pub-id-type="pmid">29045889</pub-id>
</mixed-citation>
</ref>
<ref id="B102"><label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname>
<given-names>X</given-names>
</name>
, <name name-style="western"><surname>McBride</surname>
<given-names>R</given-names>
</name>
, <name name-style="western"><surname>Nycholat</surname>
<given-names>CM</given-names>
</name>
, <name name-style="western"><surname>Yu</surname>
<given-names>W</given-names>
</name>
, <name name-style="western"><surname>Paulson</surname>
<given-names>JC</given-names>
</name>
, <name name-style="western"><surname>Wilson</surname>
<given-names>IA</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors</article-title>
. <source>J Virol</source>
<volume>86</volume>
:<fpage>13371</fpage>
–<lpage>13383</lpage>
. doi:<pub-id pub-id-type="doi">10.1128/JVI.01426-12</pub-id>
.<pub-id pub-id-type="pmid">23015718</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E488 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000E488 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Pmc |étape= Corpus |type= RBID |clé= |texte= }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |